BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr. 2020;14:303-310. [PMID: 32298981 DOI: 10.1016/j.dsx.2020.04.004] [Cited by in Crossref: 415] [Cited by in F6Publishing: 430] [Article Influence: 138.3] [Reference Citation Analysis]
Number Citing Articles
1 Lesteberg KE, Araya P, Waugh KA, Chauhan L, Espinosa JM, Beckham JD. Severely ill and high-risk COVID-19 patients exhibit increased peripheral circulation of CD62L+ and perforin+ T cells. Front Immunol 2023;14. [DOI: 10.3389/fimmu.2023.1113932] [Reference Citation Analysis]
2 Qureshi N, Desousa J, Siddiqui AZ, Drees BM, Morrison DC, Qureshi AA. Dysregulation of Gene Expression of Key Signaling Mediators in PBMCs from People with Type 2 Diabetes Mellitus. IJMS 2023;24:2732. [DOI: 10.3390/ijms24032732] [Reference Citation Analysis]
3 Khunti K, Feldman EL, Laiteerapong N, Parker W, Routen A, Peek M. The Impact of the COVID-19 Pandemic on Ethnic Minority Groups With Diabetes. Diabetes Care 2023;46:228-36. [PMID: 35944272 DOI: 10.2337/dc21-2495] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Pedrosa AR, Martins DC, Rizzo M, Silva-Nunes J. Metformin in SARS-CoV-2 infection: A hidden path - from altered inflammation to reduced mortality. A review from the literature. J Diabetes Complications 2023;37:108391. [PMID: 36621213 DOI: 10.1016/j.jdiacomp.2022.108391] [Reference Citation Analysis]
5 Kamal SM, Naghib MM, Daadour M, Alsuliman MN, Alanazi ZG, Basalem AA, Alaskar AM, Saed K. The Outcome of BNT162b2, ChAdOx1-Sand mRNA-1273 Vaccines and Two Boosters: A Prospective Longitudinal Real-World Study. Viruses 2023;15:326. [DOI: 10.3390/v15020326] [Reference Citation Analysis]
6 Ölmez H, Tosun M, Ünver E, Özer D, Karavas E, Arslan YK. Congruence of radiological scoring systems used in COVID-19 pneumonia and effect of comorbid diseases on radiological features. J Surg Med 2023;7:101-106. [DOI: 10.28982/josam.7675] [Reference Citation Analysis]
7 Nilav A, Karimi Rouzbahani A, Mahmoudvand G, Zavari T. Evaluation of the Effect of Underlying Diseases on Mortality of COVID-19 Patients: A Study of 19,985 Cases. Jundishapur J Microbiol 2023;15. [DOI: 10.5812/jjm-133603] [Reference Citation Analysis]
8 Pinchera B, Schiano Moriello N, Buonomo AR, Di Filippo I, Tanzillo A, Buzzo G, Villari R, Gentile I, Federico Ii Covid Team. Diabetes and SARS-CoV-2 Infection: The Potential Role of Antidiabetic Therapy in the Evolution of COVID-19. Microorganisms 2023;11. [PMID: 36677437 DOI: 10.3390/microorganisms11010145] [Reference Citation Analysis]
9 AlShurbaji M, Kader LA, Hannan H, Mortula M, Husseini GA. Comprehensive Study of a Diabetes Mellitus Mathematical Model Using Numerical Methods with Stability and Parametric Analysis. Int J Environ Res Public Health 2023;20. [PMID: 36673694 DOI: 10.3390/ijerph20020939] [Reference Citation Analysis]
10 Kelebeyev S, Davison W, Ford BL, Pitman MJ, Bulman WA. The Effects of Endotracheal Tube Size During Bronchoscopy in Simulated Models of Intubated Patients. Laryngoscope 2023;133:147-53. [PMID: 35218022 DOI: 10.1002/lary.30074] [Reference Citation Analysis]
11 Gordon C, Kamel B, McKeon L, Brooks D, Schulman-Rosenbaum R. Dexamethasone use and insulin requirements in coronovirus-19 (COVID-19) infection stratified by Hemoglobin A1c. Diabet Epidemiol Manag 2023;10:100123. [PMID: 36514311 DOI: 10.1016/j.deman.2022.100123] [Reference Citation Analysis]
12 Pergolizzi J, LeQuang JAK, Breve F, Magnusson PM, Varrassi G. Exploring the Implications of New-Onset Diabetes in COVID-19: A Narrative Review. Cureus 2023;15:e33319. [PMID: 36741600 DOI: 10.7759/cureus.33319] [Reference Citation Analysis]
13 Ahmed YS, Mohamed MI, Hasabo EA, Omer AT, Abdelgadir II, Bashir SN, El Hag NE. Knowledge, attitude and practices regarding COVID-19 and their associated factors in patients with type 2 diabetes attending Abdullah-Khalil diabetes center, Omdurman: A cross-sectional study. Medicine (Baltimore) 2022;101:e32561. [PMID: 36596011 DOI: 10.1097/MD.0000000000032561] [Reference Citation Analysis]
14 Tasfia SR, Sakib HA, Khanam T, Hoque N, Rahman M, Khan A, Islam S. Potential drug-drug interactions in COVID-19 comorbid patients: situation in outpatients department of different hospitals in Bangladesh.. [DOI: 10.21203/rs.3.rs-2411752/v1] [Reference Citation Analysis]
15 Artopoulou II, Kalfarentzos E, Polyzois G, Perisanidis C. Prosthodontic restoration of a COVID-19 associated mucormycosis defect: A clinical report. Spec Care Dentist 2022. [PMID: 36517205 DOI: 10.1111/scd.12809] [Reference Citation Analysis]
16 Reeves J, Kooner JS, Zhang W. Accelerated ageing is associated with increased COVID-19 severity and differences across ethnic groups may exist. Front Public Health 2022;10:1034227. [PMID: 36582365 DOI: 10.3389/fpubh.2022.1034227] [Reference Citation Analysis]
17 Zhu Z, Zeng Q, Liu Q, Wen J, Chen G. Association of Glucose-Lowering Drugs With Outcomes in Patients With Diabetes Before Hospitalization for COVID-19: A Systematic Review and Network Meta-analysis. JAMA Netw Open 2022;5:e2244652. [PMID: 36472874 DOI: 10.1001/jamanetworkopen.2022.44652] [Reference Citation Analysis]
18 Sun H, Du Y, Kumar R, Buchkovich N, He P. Increased circulating microparticles contribute to severe infection and adverse outcomes of COVID-19 in patients with diabetes. Am J Physiol Heart Circ Physiol 2022;323:H1176-93. [PMID: 36269646 DOI: 10.1152/ajpheart.00409.2022] [Reference Citation Analysis]
19 Zhao Y, Zhang X, Liang H, Wang L. Antidiabetic agents: Do they hit the right targets? Frigid Zone Medicine 2022;2:225-243. [DOI: 10.2478/fzm-2022-0030] [Reference Citation Analysis]
20 Federica Calò, Antonio Russo, Mariagrazia Palamone, Paolo Maggi, Enrico Allegorico, Ivan Gentile, Vincenzo Sangiovanni, Annamaria Russomando, Valeria Gentile, Giosuele Calabria, Raffaella Pisapia, Angelo Salomone Megna, Alfonso Masullo, Valentina Iodice, Grazia Russo, Roberto Parrella, Giuseppina Dell’Aquila, Michele Gambardella, Antonio Ponticiello, Mariantonietta Pisaturo, Nicola Coppola, on behalf of CoviCam group. Pre-existing chronic kidney disease (CDK) was not associated with a severe clinical outcome of hospitalized COVID-19: results of a case-control study in Southern Italy. Infez Med 2022;30. [PMID: 36482947 DOI: 10.53854/liim-3004-8] [Reference Citation Analysis]
21 Novida H, Soelistyo SA, Cahyani C, Siagian N, Hadi U, Pranoto A. Factors associated with disease severity of COVID‑19 in patients with type 2 diabetes mellitus. Biomed Rep 2023;18:8. [PMID: 36570802 DOI: 10.3892/br.2022.1590] [Reference Citation Analysis]
22 Huang X, Gupta V, Feng C, Yang F, Zhang L, Zheng J, Van Wart M. How National Culture Influences the Speed of COVID-19 Spread: Three Cross-Cultural Studies. Cross-Cultural Research 2022. [DOI: 10.1177/10693971221141478] [Reference Citation Analysis]
23 Hardy YO, Libhaber E, Ofori E, Amenuke DAY, Kontoh SA, Dankwah JA, Larsen-Reindorf R, Otu-Ansah C, Hutton-Mensah K, Dadson E, Adamu S, Akyerekoh K, Sarfo FS, Nkum B. Clinical and laboratory profile and outcomes of hospitalized COVID-19 patients with type 2 diabetes mellitus in Ghana - A single-center study. Endocrinol Diabetes Metab 2023;6:e391. [PMID: 36426913 DOI: 10.1002/edm2.391] [Reference Citation Analysis]
24 Tolossa T, Lema M, Wakuma B, Turi E, Fekadu G, Mulisa D, Fetensa G. Incidence and predictors of diabetes mellitus among severe COVID-19 patients in western Ethiopia: a retrospective cohort study. Journal of Endocrinology, Metabolism and Diabetes of South Africa 2022. [DOI: 10.1080/16089677.2022.2144016] [Reference Citation Analysis]
25 Alharbi A, Alduribi A, Alghthami A, Elnaem M, Alsenani FS, Haseeb A, Ahmed NJ, Elrggal M. Coping With Diabetes During the COVID-19 Lockdown in Saudi Arabia: Lessons Learned in the Post-pandemic Era. Cureus 2022. [DOI: 10.7759/cureus.31522] [Reference Citation Analysis]
26 Sane AH, Mnekonnen MS, Tsegaw MG, Zewde WC, Mesfin EG, Beyene HA, Ashine TM, Tiruneh KG, Mengistie MA. New Onset of Diabetes Mellitus and Associated Factors among COVID-19 Patients in COVID-19 Care Centers, Addis Ababa, Ethiopia 2022. Journal of Diabetes Research 2022;2022:1-9. [DOI: 10.1155/2022/9652940] [Reference Citation Analysis]
27 Al-kuraishy HM, Al-gareeb AI, Albogami SM, Jean-marc S, Nadwa EH, Hafiz AA, A. Negm W, Kamal M, Al-jouboury M, Elekhnawy E, Batiha GE, Waard MD. Potential Therapeutic Benefits of Metformin Alone and in Combination with Sitagliptin in the Management of Type 2 Diabetes Patients with COVID-19. Pharmaceuticals 2022;15:1361. [DOI: 10.3390/ph15111361] [Reference Citation Analysis]
28 Rodríguez CE, Mena RH. COVID‐19 clinical footprint to infer about mortality. Royal Stats Society Series A 2022. [DOI: 10.1111/rssa.12947] [Reference Citation Analysis]
29 Gherbon A, Frandes M, Timar R, Timar B. The Impact of COVID-19 Lockdown on Glycemic Balance in Romanian Patients with Type 1 Diabetes Mellitus. Diabetes Metab Syndr Obes 2022;15:3403-13. [PMID: 36349052 DOI: 10.2147/DMSO.S386614] [Reference Citation Analysis]
30 Wong R, Vaddavalli R, Hall MA, Patel MV, Bramante CT, Casarighi E, Johnson SG, Lingam V, Miller JD, Reusch J, Saltz M, Stürmer T, Tronieri JS, Wilkins KJ, Buse JB, Saltz J, Huling JD, Moffitt R; N3C Consortium:. Effect of SARS-CoV-2 Infection and Infection Severity on Longer-Term Glycemic Control and Weight in People With Type 2 Diabetes. Diabetes Care 2022;45:2709-17. [PMID: 36098660 DOI: 10.2337/dc22-0730] [Reference Citation Analysis]
31 Fitero A, Bungau SG, Tit DM, Endres L, Khan SA, Bungau AF, Romanul I, Vesa CM, Radu A, Tarce AG, Bogdan MA, Nechifor AC, Negrut N. Comorbidities, Associated Diseases, and Risk Assessment in COVID-19—A Systematic Review. International Journal of Clinical Practice 2022;2022:1-24. [DOI: 10.1155/2022/1571826] [Reference Citation Analysis]
32 Copur B, Surme S, Sayili U, Tuncer G, Ozcelik MN, Yilmaz-ak H, Topal M, Ustun-al S, Pehlivanoglu F, Sengoz G. Blood types (ABO/Rhesus) and SARS-CoV-2 infection: a retrospective, cross-sectional study in 2828 healthcare workers. Future Virology. [DOI: 10.2217/fvl-2022-0128] [Reference Citation Analysis]
33 Lundstrom K, Hromić-Jahjefendić A, Bilajac E, Aljabali AAA, Baralić K, Sabri NA, Shehata EM, Raslan M, Ferreira ACBH, Serrano-Aroca Á, Tambuwala MM, Uversky VN, Azevedo V, Alzahrani KJ, Alsharif KF, Halawani IF, Alzahrani FM, Barh D. COVID-19 signalome: Pathways for SARS-CoV-2 infection and impact on COVID-19 associated comorbidity. Cell Signal 2022;:110495. [PMID: 36252792 DOI: 10.1016/j.cellsig.2022.110495] [Reference Citation Analysis]
34 Mahmoudi H. The Role of Secondary Infections and Underlying Diseases in the Mortality of Patients with COVID-19. TOPHJ 2022;15. [DOI: 10.2174/18749445-v15-e2206294] [Reference Citation Analysis]
35 Parikh P, Greenberg P, Halpert S, Abrishami A, Rabizadeh L, Shayefar H, Tetelbaun L, Friedman D, Kaminetzky J. Mitigating the Severity of COVID-19 Illness in the Primary Care Patient Population through Early Identification and Close Monitoring of Underlying Comorbidities.. [DOI: 10.1101/2022.10.07.22280827] [Reference Citation Analysis]
36 Shi Y, Hu Y, Xu G, Ke Y, Huang T. A Prognostic Model for the Respiratory Function of Patients with Nonsevere Pulmonary Infection Based on Breathing Exercises and Acupuncture Therapy: Development and Validation. Computational and Mathematical Methods in Medicine 2022;2022:1-6. [DOI: 10.1155/2022/9057575] [Reference Citation Analysis]
37 Cancarevic I, Nassar M, Daoud A, Ali H, Nso N, Sanchez A, Parikh A, Ul Hosna A, Devanabanda B, Ahmed N, Soliman KM. Mortality rate of COVID-19 infection in end stage kidney disease patients on maintenance hemodialysis: A systematic review and meta-analysis. World J Virol 2022; 11(5): 352-361 [DOI: 10.5501/wjv.v11.i5.352] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Justino DCP, Silva DFO, Costa KTDS, de Morais TNB, de Andrade FB. Prevalence of comorbidities in deceased patients with COVID-19: A systematic review. Medicine 2022;101:e30246. [DOI: 10.1097/md.0000000000030246] [Reference Citation Analysis]
39 Watkins TA, Nguyen K, Ali H, Gummakonda R, Pelman J, Taracena B. The impact of access to financial services on mitigating COVID-19 mortality globally.. [DOI: 10.1101/2022.09.12.22279872] [Reference Citation Analysis]
40 Eseadi C, Ossai OV, Onyishi CN, Ilechukwu LC. Assisting individuals with diabetes in the COVID-19 pandemic period: Examining the role of religious factors and faith communities. World J Clin Cases 2022; 10(26): 9180-9191 [DOI: 10.12998/wjcc.v10.i26.9180] [Reference Citation Analysis]
41 Gavkare AM, Nanaware N, Rayate AS, Mumbre S, Nagoba BS. COVID-19 associated diabetes mellitus: A review. World J Diabetes 2022; 13(9): 729-737 [DOI: 10.4239/wjd.v13.i9.729] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
42 Otake S, Chubachi S, Namkoong H, Nakagawara K, Tanaka H, Lee H, Morita A, Fukushima T, Watase M, Kusumoto T, Masaki K, Kamata H, Ishii M, Hasegawa N, Harada N, Ueda T, Ueda S, Ishiguro T, Arimura K, Saito F, Yoshiyama T, Nakano Y, Mutoh Y, Suzuki Y, Murakami K, Okada Y, Koike R, Kitagawa Y, Kimura A, Imoto S, Miyano S, Ogawa S, Kanai T, Fukunaga K; The Japan COVID-19 Task Force. Clinical clustering with prognostic implications in Japanese COVID-19 patients: report from Japan COVID-19 Task Force, a nation-wide consortium to investigate COVID-19 host genetics. BMC Infect Dis 2022;22. [DOI: 10.1186/s12879-022-07701-y] [Reference Citation Analysis]
43 Ruiz-Álvarez MJ, Stampone E, Verduras YF, Gallo G, González MB, Cubillo BB, Bencivenga D, Della Ragione F, Borriello A. Hypocalcemia: a key biomarker in hospitalized COVID-19 patients. Biomed J 2022:S2319-4170(22)00134-2. [PMID: 36038109 DOI: 10.1016/j.bj.2022.08.005] [Reference Citation Analysis]
44 Agrawal H, Jain P, Joshi AM. Machine learning models for non-invasive glucose measurement: towards diabetes management in smart healthcare. Health Technol . [DOI: 10.1007/s12553-022-00690-7] [Reference Citation Analysis]
45 Atlasi R, Tabatabaei-malazy O, Bandarian F, Rezaei N, Khashayar P, Larijani B. Scientometric Analysis of Global Scientific Publications on COVID-19 and Diabetes with an Emphasis on Middle Eastern Countries. Int J Endocrinol Metab 2022;20. [DOI: 10.5812/ijem-120812] [Reference Citation Analysis]
46 Wang W, Chai Z, Cooper ME, Zimmet PZ, Guo H, Ding J, Yang F, Lin X, Chen X, Wang X, Zhong Q, Li Z, Zhang P, Wu Z, Guan X, Zhang L, He K. Elevated Fasting Blood Glucose Levels Are Associated with Worse Clinical Outcomes in COVID-19 Patients Than in Pneumonia Patients with Bacterial Infections. Pathogens 2022;11:902. [DOI: 10.3390/pathogens11080902] [Reference Citation Analysis]
47 Wilson V. COVID-19 and diabetes: onset and challenges in management. Primary Health Care 2022;32:17-22. [DOI: 10.7748/phc.2022.e1766] [Reference Citation Analysis]
48 Makhoul E, Aklinski JL, Miller J, Leonard C, Backer S, Kahar P, Parmar MS, Khanna D. A Review of COVID-19 in Relation to Metabolic Syndrome: Obesity, Hypertension, Diabetes, and Dyslipidemia. Cureus 2022. [DOI: 10.7759/cureus.27438] [Reference Citation Analysis]
49 Gonçalves C, Sesterheim P, Wartchow KM, Bobermin LD, Leipnitz G, Quincozes-santos A. Why antidiabetic drugs are potentially neuroprotective during the Sars-CoV-2 pandemic: The focus on astroglial UPR and calcium-binding proteins. Front Cell Neurosci 2022;16:905218. [DOI: 10.3389/fncel.2022.905218] [Reference Citation Analysis]
50 Solmaz İ, Araç S. Does the frequency of diabetes increase in Covid-19 patients? cross-sectional study. DAHUDER MJ 2022. [DOI: 10.56016/dahudermj.1146367] [Reference Citation Analysis]
51 Kelesidis T, Mantzoros CS. Cross-talk between SARS-CoV-2 infection and the insulin/IGF signaling pathway: Implications for metabolic diseases in COVID-19 and for post-acute sequelae of SARS-CoV-2 infection. Metabolism 2022;134:155267. [PMID: 35901934 DOI: 10.1016/j.metabol.2022.155267] [Reference Citation Analysis]
52 Zaghloul H, Malik RA. COVID-19 and the hidden threat of diabetic microvascular complications. Ther Adv Endocrinol Metab 2022;13:20420188221110708. [PMID: 35847423 DOI: 10.1177/20420188221110708] [Reference Citation Analysis]
53 Gaba U, Altamish M, Azharuddin M, Adil M, Ghosh P, Gyawali B, Yadav Y, Sharma M. Risk factors and outcomes associated with diabetes mellitus in COVID-19 patients: a meta-analytic synthesis of observational studies. J Diabetes Metab Disord. [DOI: 10.1007/s40200-022-01072-6] [Reference Citation Analysis]
54 Tannus LRM, Zapelini RM, Cabizuca CA, Abi-Abib RC, Matheus ASM, Calassara PC, Pozzan R, Cobas RA. Effect of the COVID-19 pandemic on glycemic control in Brazilian patients with type 2 diabetes. Endocrine 2022. [PMID: 35838896 DOI: 10.1007/s12020-022-03137-1] [Reference Citation Analysis]
55 Huang XY, Yang LJ, Hu X, Zhang XX, Gu X, Du LJ, He ZY, Gu XJ. Elevated levels of fructosamine are independently associated with SARS-CoV-2 reinfection: A 12-mo follow-up study. World J Diabetes 2022; 13(7): 543-552 [DOI: 10.4239/wjd.v13.i7.543] [Reference Citation Analysis]
56 Ahmadi Darmian M, Hoseini R, Amiri E, Golshani S. The Interactive Effect of Home-Based Aerobic Training and Turmeric Supplementation on the Quality of Life in Type 2 Diabetic Women. J Kermanshah Univ Med Sci 2022;26. [DOI: 10.5812/jkums-115917] [Reference Citation Analysis]
57 Pradhan A, Prabhu S, Chadaga K, Sengupta S, Nath G. Supervised Learning Models for the Preliminary Detection of COVID-19 in Patients Using Demographic and Epidemiological Parameters. Information 2022;13:330. [DOI: 10.3390/info13070330] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
58 Vaishya R, Misra A. International rankings of Diabetes and Metabolic diseases related journals in comparison to other medical journals from India. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2022. [DOI: 10.1016/j.dsx.2022.102559] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Sayed AA, Abdelfatah HH, Abdelhameid MA, Ali OM. Different Aspects of Diabetes in Hospitalized Patients with COVID-19. Int J Gen Med 2022;15:5729-40. [PMID: 35761893 DOI: 10.2147/IJGM.S360160] [Reference Citation Analysis]
60 Bajpai S, Gaur S, Gaur S, Singhal S, Mishra R. Coronavirus disease 2019 in diabetes: A pathophysiological linkage. IJCBR 2022;9:92-97. [DOI: 10.18231/j.ijcbr.2022.019] [Reference Citation Analysis]
61 Rosa L, Vincenzo M, Annalisa C, Federica I, Giordano S, Giada P, Marco P, Irene M, Beatrice M, Elisa F, Matteo C, Alessandra B, Luca V, Flora P, Nicola M, Marina B, Ludovica FA. Usefulness of fibrosis-4 (FIB-4) score and metabolic alterations in the prediction of SARS-CoV-2 severity. Intern Emerg Med 2022. [PMID: 35754075 DOI: 10.1007/s11739-022-03000-1] [Reference Citation Analysis]
62 Kumar S, Rai N, Bansal A, Mittal A, Chandra NC. A Pilot Study on COVID-19 Positive Subjects: An Excerpt of Post-Infection-Pro-Diabetic Disposition & Related Consequences in Correlation to Hepato-Pancreatic Bio-Markers, Pro-Inflammatory Cytokines and Other Risk Factors. Indian J Clin Biochem 2022;:1-11. [PMID: 35756691 DOI: 10.1007/s12291-022-01054-8] [Reference Citation Analysis]
63 Al-Taie A, Arueyingho O, Khoshnaw J, Hafeez A. Clinical outcomes of multidimensional association of type 2 diabetes mellitus, COVID-19 and sarcopenia: an algorithm and scoping systematic evaluation. Arch Physiol Biochem 2022;:1-19. [PMID: 35704400 DOI: 10.1080/13813455.2022.2086265] [Reference Citation Analysis]
64 Singh R, Rathore SS, Khan H, Karale S, Chawla Y, Iqbal K, Bhurwal A, Tekin A, Jain N, Mehra I, Anand S, Reddy S, Sharma N, Sidhu GS, Panagopoulos A, Pattan V, Kashyap R, Bansal V. Association of Obesity With COVID-19 Severity and Mortality: An Updated Systemic Review, Meta-Analysis, and Meta-Regression. Front Endocrinol 2022;13:780872. [DOI: 10.3389/fendo.2022.780872] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
65 Vedachalam R, Yamini K, Venkatesh R, Kalpana N, Shivkumar C, Shekhar M, Haripriya A, Sathya R. Reasons for delay in cataract surgery in patients with advanced cataracts during the COVID-19 pandemic. Indian J Ophthalmol 2022;70:2153-7. [PMID: 35648002 DOI: 10.4103/ijo.IJO_544_22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Krishnasamy S, Sheikh D, Ali T, Clemons V, Furmanek S, Mohamed Fawzy Abdelhaleem AA, Salunkhe V, Akbar UA, Chlebowy D, Ramirez J, Arnold F. Impact of hyperglycemia on cardiovascular events and clinical outcomes in patients hospitalized with COVID-19 pneumonia. Endocrine Practice 2022. [DOI: 10.1016/j.eprac.2022.05.011] [Reference Citation Analysis]
67 Bailey KL, Sayles H, Campbell J, Khalid N, Anglim M, Ponce J, Wyatt TA, McClay JC, Burnham EL, Anzalone A, Hanson C. COVID-19 patients with documented alcohol use disorder or alcohol-related complications are more likely to be hospitalized and have higher all-cause mortality. Alcohol Clin Exp Res 2022;46:1023-35. [PMID: 35429004 DOI: 10.1111/acer.14838] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
68 Melena I, Piani F, Tommerdahl KL, Severn C, Chung LT, MacDonald A, Vinovskis C, Cherney D, Pyle L, Roncal-Jimenez CA, Lanaspa MA, Rewers A, van Raalte DH, Cara-Fuentes G, Parikh CR, Nelson RG, Pavkov ME, Nadeau KJ, Johnson RJ, Bjornstad P. Aminoaciduria and metabolic dysregulation during diabetic ketoacidosis: Results from the diabetic kidney alarm (DKA) study. J Diabetes Complications 2022;36:108203. [PMID: 35523653 DOI: 10.1016/j.jdiacomp.2022.108203] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Selvaraj M, Loganathan L, Jayaraj JM, Gopinath K, Rajendran K, Pannipara M, Al-sehemi AG, Muthusamy K. In silico Investigation of Immunodominant Antigenic Regions, Helper T Lymphocyte, and Cytotoxic T Lymphocyte Epitopes Credentials for SARS-CoV-2 Vaccination. CCS 2022;2:226-242. [DOI: 10.2174/2210298102666220224115100] [Reference Citation Analysis]
70 Merga BT, Ayana GM, Raru TB, Alemu A, Negash B, Bekana M, Birhanu A, Dessie Y. Association of Pre-Existing Comorbidities with Disease Severity Among COVID-19 Patients in Eastern Ethiopia. IDR 2022;Volume 15:2825-34. [DOI: 10.2147/idr.s362140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Shahrokh S, Baradaran Ghavami S, Asadzadeh Aghdaei H, Parigi TL, Farmani M, Danese S, Ebrahimi Daryani N, Vossoughinia H, Balaii H, Alborzi F, Khoramjoo SM, Khanabadi B, Seyed Salehi A, Bastani A, Sharifi M, Safari MT, Malekpour H, Sherkat G, Saberafsharian M, Miri MB, Moosavi SH, Anaraki F, Nazemalhosseini-Mojarad E, Mohebi SR, Shojaie S, Pourhoseingholi MA, Zali MR. High prevalence of SARS-Coronavirus-2 in patients with inflammatory bowel disease and the role of soluble angiotensin converting Enzyme2. Arch Physiol Biochem 2022;:1-8. [PMID: 35617972 DOI: 10.1080/13813455.2022.2080228] [Reference Citation Analysis]
72 Yassin Z, Tan YL, Srv A, Monro J, Matia-Merino L, Lim K, Hardacre A, Mishra S, Goh KKT. Effects of Xanthan Gum, Lambda-Carrageenan and Psyllium Husk on the Physical Characteristics and Glycaemic Potency of White Bread. Foods 2022;11:1513. [PMID: 35627083 DOI: 10.3390/foods11101513] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Seetaha S, Khamplong P, Wanaragthai P, Aiebchun T, Ratanabunyong S, Krobthong S, Yingchutrakul Y, Rattanasrisomporn J, Choowongkomon K. KERRA, Mixed Medicinal Plant Extracts, Inhibits SARS-CoV-2 Targets Enzymes and Feline Coronavirus. COVID 2022;2:621-632. [DOI: 10.3390/covid2050046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Asim M, Rahatullah A, Wahid K, Wahid F. Investigating the interrelatedness of clinical and non-clinical parameters affecting outcomes in COVID-19 patients: a retrospective study. Pathog Glob Health 2022;:1-7. [PMID: 35469550 DOI: 10.1080/20477724.2022.2064796] [Reference Citation Analysis]
75 Riley P, Riley A, Turtle J, Ben-nun M. COVID-19 deaths: Which explanatory variables matter the most? PLoS ONE 2022;17:e0266330. [DOI: 10.1371/journal.pone.0266330] [Reference Citation Analysis]
76 Yilmaz Phd. Rn, Associate Prof FT, Cetindag Ciltas A. Prevalence of COVID-19 Infection in Type 2 Diabetes Patients and Their Anxiety Levels. Prog Health Sci 2022;12:66-74. [DOI: 10.5604/01.3001.0015.8835] [Reference Citation Analysis]
77 Altin Z, Yasar HY. The effect of diabetes mellitus on disease prognosis in COVID-19 patients. Ir J Med Sci 2022. [PMID: 35411486 DOI: 10.1007/s11845-022-03001-1] [Reference Citation Analysis]
78 Machado CV, Oliveira SCD, Pereira AMM. Panorama global e cenários nacionais da pandemia. Políticas e sistemas de saúde em tempos de pandemia: nove países, muitas lições 2022. [DOI: 10.7476/9786557081594.0002] [Reference Citation Analysis]
79 Bailey CJ, Gwilt M. Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin. Front Pharmacol 2022;13:784459. [PMID: 35370738 DOI: 10.3389/fphar.2022.784459] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
80 Mekonnen MS, Tsegaw MG, Zewde WC, Tiruneh KG, Sane AH, Ashine TM, Beyene HA, Mengistie MA, Mesfin EG. Determinants of mortality among COVID-19 patients with diabetes mellitus in Addis Ababa, Ethiopia, 2022: An unmatched case-control study.. [DOI: 10.1101/2022.04.04.22273344] [Reference Citation Analysis]
81 Velsitharth M, Bridger H, Aattralarasu NR. PREDICTING MORTALITY OF COVID PATIENTS WITH COMORBIDITIES (Review Article). jecm 2022. [DOI: 10.52340/jecm.2022.02.18] [Reference Citation Analysis]
82 Pinchera B, Scotto R, Buonomo AR, Zappulo E, Stagnaro F, Gallicchio A, Viceconte G, Sardanelli A, Mercinelli S, Villari R, Foggia M, Gentile I; Federico II COVID Team. Diabetes and COVID-19: The potential role of mTOR. Diabetes Res Clin Pract 2022;186:109813. [PMID: 35248653 DOI: 10.1016/j.diabres.2022.109813] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
83 Elnaem MH, Nuffer W. Diabetes care and prevention services provided by pharmacists: Progress made during the COVID-19 pandemic and the need for additional efforts in the post-pandemic era. Exploratory Research in Clinical and Social Pharmacy 2022. [DOI: 10.1016/j.rcsop.2022.100137] [Reference Citation Analysis]
84 Leite NJC, Raimundo AMM, Mendes RDC, Marmeleira JFF. Impact of COVID-19 Pandemic on Daily Life, Physical Exercise, and General Health among Older People with Type 2 Diabetes: A Qualitative Interview Study. IJERPH 2022;19:3986. [DOI: 10.3390/ijerph19073986] [Reference Citation Analysis]
85 Mosharaf MP, Reza MS, Kibria MK, Ahmed FF, Kabir MH, Hasan S, Mollah MNH. Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing. Sci Rep 2022;12:4279. [PMID: 35277538 DOI: 10.1038/s41598-022-08073-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
86 Wang J, Chang H, Qiao Y, Sun H, Li X, Yuan S, Zhang S, Shan C. Angiotensin converting enzyme 2 (ACE2): Virus accomplice or host defender.. [DOI: 10.1101/2022.03.06.483197] [Reference Citation Analysis]
87 Tourkmani AM, Rsheed AMB, Aleissa MS, Alqahtani SM, Alotaibi AF, Almujil MS, Alkhashan IH, Alnassar TN, Alotaibi MN, Alrasheedy AA. Prevalence of COVID-19 Infection among Patients with Diabetes and Their Vaccination Coverage Status in Saudi Arabia: A Cross-Sectional Analysis from a Hospital-Based Diabetes Registry. Vaccines 2022;10:310. [DOI: 10.3390/vaccines10020310] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
88 Kaviani M, Keshtkar S, Soleimanian S, Sabet Sarvestani F, Azarpira N, Pakbaz S. Susceptibility to Metabolic Diseases in COVID-19: To be or Not to be an Issue. Front Mol Biosci 2022;9:803314. [DOI: 10.3389/fmolb.2022.803314] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
89 Clemente-Suárez VJ, Beltrán-Velasco AI, Ramos-Campo DJ, Mielgo-Ayuso J, Nikolaidis PA, Belando N, Tornero-Aguilera JF. Physical activity and COVID-19. The basis for an efficient intervention in times of COVID-19 pandemic. Physiol Behav 2022;244:113667. [PMID: 34861297 DOI: 10.1016/j.physbeh.2021.113667] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 19.0] [Reference Citation Analysis]
90 Knox DB, Hirshberg EL, Orme J, Peltan I, Lanspa MJ. Effect of COVID 19 pneumonia on hyperglycemia: Is it different from non COVID pneumonia? Diabetes Metab Syndr 2022;16:102407. [PMID: 35074624 DOI: 10.1016/j.dsx.2022.102407] [Reference Citation Analysis]
91 Elrayess MA, Cyprian FS, Abdallah AM, Emara MM, Diboun I, Anwardeen N, Schuchardt S, Yassine HM. Metabolic Signatures of Type 2 Diabetes Mellitus and Hypertension in COVID-19 Patients With Different Disease Severity. Front Med (Lausanne) 2021;8:788687. [PMID: 35083246 DOI: 10.3389/fmed.2021.788687] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
92 Singh AK, Khunti K. COVID-19 and Diabetes. Annu Rev Med 2022;73:129-147. [DOI: 10.1146/annurev-med-042220-011857] [Cited by in Crossref: 11] [Article Influence: 11.0] [Reference Citation Analysis]
93 Butt B, Hussain T, Jarrar M, Khalid K, Albaker W, Ambreen A, Waheed Y. Efficacy and Safety of Remdesivir in COVID-19 Positive Dialysis Patients. Antibiotics (Basel) 2022;11:156. [PMID: 35203759 DOI: 10.3390/antibiotics11020156] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
94 Roy Biswas RS, Nath JD, Nisha FE. Death review caused by Covid 19 in Bangladesh.. [DOI: 10.1101/2022.01.23.22269626] [Reference Citation Analysis]
95 Masoodi M, Peschka M, Schmiedel S, Haddad M, Frye M, Maas C, Lohse A, Huber S, Kirchhof P, Nofer J, Renné T. Disturbed lipid and amino acid metabolisms in COVID-19 patients. J Mol Med. [DOI: 10.1007/s00109-022-02177-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
96 Subbaram K, Ali PSS, Ali S. Enhanced endocytosis elevated virulence and severity of SARS-CoV-2 due to hyperglycemia in type 2 diabetic patients. Gene Rep 2022;26:101495. [PMID: 35043090 DOI: 10.1016/j.genrep.2022.101495] [Reference Citation Analysis]
97 Bonakdaran S, Layegh P, Hasani S, Afkhamizadeh M, Khorasani ZM, Mohebbi M, Vojouhi S, Mousavi Z, Aboutorabi RB, Mehrad-majd H, Sahebkar A, Yaghoubi MA, Sainaghi PP. The Prognostic Role of Metabolic and Endocrine Parameters for the Clinical Severity of COVID-19. Disease Markers 2022;2022:1-8. [DOI: 10.1155/2022/5106342] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
98 Goyal A, Tiwari N, Patawa R. Co-Morbidity and COVID-19: A Study of Case Severity and Early Outcome. J CLIN EXP INVEST 2022;13:em00790. [DOI: 10.29333/jcei/11583] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Toori KU, Qureshi MA, Chaudhry A. Pre-morbidity and COVID-19 disease outcomes in Pakistani population: A cross-sectional study. Pak J Med Sci 2022;38:287-92. [PMID: 35035441 DOI: 10.12669/pjms.38.1.4235] [Reference Citation Analysis]
100 Tazerji SS, Shahabinejad F, Tokasi M, Rad MA, Khan MS, Safdar M, Filipiak KJ, Szarpak L, Dzieciatkowski T, Jurgiel J, Duarte PM, Rahman MT, Sobur MA, Islam MS, Ahmed A, Shahen MNF, Shehata AA, Gharieb R, Fawzy M, Malik YS, Jaganathasamy N, Rajendran VO, Subbaram K, Pakeer SSA, Ali S, Rehman SU, Ozaslan M, Khan G, Saeed M, Younas U, Imran S, Junejo Y, Arabkarami P, Hogan U, Rodriguez-Morales AJ. Global data analysis and risk factors associated with morbidity and mortality of COVID-19. Gene Rep 2022;:101505. [PMID: 35071820 DOI: 10.1016/j.genrep.2022.101505] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
101 Chikhalkar B, Gosain D, Gaikwad S, Deshmukh R. Assessment of National Early Warning Score 2 as a Tool to Predict the Outcome of COVID-19 Patients on Admission. Cureus 2022. [DOI: 10.7759/cureus.21164] [Reference Citation Analysis]
102 Al Ali H, Daneshkhah A, Boutayeb A, Mukandavire Z. Examining Type 1 Diabetes Mathematical Models Using Experimental Data. Int J Environ Res Public Health 2022;19:737. [PMID: 35055576 DOI: 10.3390/ijerph19020737] [Reference Citation Analysis]
103 Kaur R, Singh S, Singh TG, Sood P, Robert J. Covid-19: pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination. Inflammopharmacology 2022. [PMID: 34981320 DOI: 10.1007/s10787-021-00904-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Carballo Molina L, Sánchez Díaz JS, Peniche Moguel KG, González Escudero EA, Martínez Aguilar FR, Calyeca Sánchez MV. El índice de anaerobiosis predice mortalidad en neumonía grave por SARS-CoV-2. Medicina Crítica 2022;36:9-13. [DOI: 10.35366/104470] [Reference Citation Analysis]
105 Hentsch L, Cocetta S, Allali G, Santana I, Eason R, Adam E, Janssens J. Dificultad respiratoria y COVID-19: Un llamado a la investigación. Kompass Neumol 2022;4:21-28. [DOI: 10.1159/000521663] [Reference Citation Analysis]
106 Sonkar G, Singh S, Sonkar S. A systematic review approach in understanding the COVID-19 mechanism in diabetes and its progression to diabetic microvascular complications. J Diabetol 2022;13:322. [DOI: 10.4103/jod.jod_87_22] [Reference Citation Analysis]
107 Chen J, Zhao C, Huang Y, Wang H, Lu X, Zhao W, Gao W. Malnutrition predicts poor outcomes in diabetic COVID-19 patients in Huangshi, Hubei. J Biomed Res 2022;36:32. [DOI: 10.7555/jbr.35.20210083] [Reference Citation Analysis]
108 Bik-Multanowska K, Mikocka-Walus A, Fernando J, Westrupp E. Mental distress of parents with chronic diseases during the COVID-19 pandemic in Australia: A prospective cohort study. J Psychosom Res 2021;152:110688. [PMID: 34875464 DOI: 10.1016/j.jpsychores.2021.110688] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
109 Zörgő S, Jeney A, Csajbók-veres K, Mkhitaryan S, Susánszky A. Mapping the Content Structure of Online Diabetes Support Group Activity on Facebook. Communications in Computer and Information Science 2022. [DOI: 10.1007/978-3-030-93859-8_15] [Reference Citation Analysis]
110 Singh J, Swain J, Manglunia A, Mangaraj S, Sravya S, Jadhao P. Assessment of knowledge and practice trends about COVID-19 disease and vaccination among patients with type 2 diabetes mellitus attending an outpatient department of a tertiary care hospital. J Appl Sci Clin Pract 2022;3:8. [DOI: 10.4103/jascp.jascp_24_21] [Reference Citation Analysis]
111 Eldeeb M, Fthenou E, Elkousy N, Sheikh N, Nasr M, Afifi N, Al Thani A, Frenneaux M. Common Indications for Referral to the Healthcare system for COVID-19 recovered patients versus Qatar Biobank study population: A descriptive analysis. Acta Biomed 2022;93:e2022033. [PMID: 35315407 DOI: 10.23750/abm.v93i1.11887] [Reference Citation Analysis]
112 Natalicchio A, Sculco C, Belletti G, Fontanelli M, Galeone C, Bossi AC. Patient-Support Program in Diabetes Care During the Covid-19 Pandemic: An Italian Multicentric Experience. PPA 2022;Volume 16:113-22. [DOI: 10.2147/ppa.s343949] [Reference Citation Analysis]
113 Sosnowska B, Bielecka-dabrowa A, Banach M. Prognosis in COVID-19 Patients: Statistics, Risk Factors. Contemporary Cardiology 2022. [DOI: 10.1007/978-3-031-15478-2_5] [Reference Citation Analysis]
114 Vargas García IJ, Sánchez Díaz JS, Peniche Moguel KG, González Escudero EA, García García VD, Calyeca Sánchez MV. Decúbito prono prolongado: una estrategia no ventilatoria en neumonía grave por SARS-CoV-2. Medicina Crítica 2022;36:197-201. [DOI: 10.35366/105789] [Reference Citation Analysis]
115 Hentsch L, Cocetta S, Allali G, Santana I, Eason R, Adam E, Janssens J. Atemnot und COVID-19: Ein Aufruf zu mehr Forschung. Kompass Pneumol 2022;10:6-14. [DOI: 10.1159/000521460] [Reference Citation Analysis]
116 Madan K, Rastogi R, Bhargava R, Dagar V, Singla V, Sahu A, Singh P, Garg P, Aggarwal B, Singh RK. Is Fatty Liver Associated with Increased Mortality and Morbidity in Coronavirus Disease 2019 (COVID-19) Pneumonia? J Clin Exp Hepatol 2022;12:1320-7. [PMID: 35469129 DOI: 10.1016/j.jceh.2022.04.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
117 Pandit RA, Gagana BN, Vaity C, Mulakavalupil B, Choudhary JS, Jain V, Chandan PM, Joshi H. Clinical Characteristics and Outcomes of COVID-19 Patients Hospitalized in Intensive Care Unit. Indian J Crit Care Med 2021;25:992-1000. [PMID: 34963716 DOI: 10.5005/jp-journals-10071-23945] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
118 Saikia AM, Hazarika MH, Islam U, Ghosh KK, Bora SK, Sarkar AH. Clinico-Epidemiological Correlates of COVID-19 Cases - A Cross-Sectional Study from Assam, India. jemds 2021;10:3947-3952. [DOI: 10.14260/jemds/2021/797] [Reference Citation Analysis]
119 Petino Zappala MA, Folguera G, Benitez-vieyra S. Testing the phenotypic decanalization hypothesis: social determinants of hyperglycemia and type 2 diabetes in adult urban Argentinian population.. [DOI: 10.1101/2021.12.24.21268333] [Reference Citation Analysis]
120 Shrivastava SR, Bobhate P. COVID-19 and Mucormycosis: Predisposing Factors and Preventive Strategies. SBV Journal of Basic, Clinical and Applied Health Science 2021;4:92-94. [DOI: 10.5005/jp-journals-10082-03126] [Reference Citation Analysis]
121 Lazareva MA, Evseeva GP, Suprun SV, Rakitskaya EV, Lebed’ko OA. Effect of COVID-19 on development and progression of endocrinopathies in children. Bûlletenʹ fiziologii i patologii dyhaniâ 2021. [DOI: 10.36604/1998-5029-2021-82-116-128] [Reference Citation Analysis]
122 Allen RJ, Guillen-guio B, Croot E, Kraven LM, Moss S, Stewart I, Jenkins RG, Wain LV. Genetic overlap between idiopathic pulmonary fibrosis and COVID−19.. [DOI: 10.1101/2021.12.08.21267459] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
123 Xie L, Zhang Z, Wang Q, Chen Y, Lu D, Wu W. COVID-19 and Diabetes: A Comprehensive Review of Angiotensin Converting Enzyme 2, Mutual Effects and Pharmacotherapy. Front Endocrinol (Lausanne) 2021;12:772865. [PMID: 34867819 DOI: 10.3389/fendo.2021.772865] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
124 de Vasconcelos PHC, Gomes DL, Uliana GC, Costa E Silva AA. Social Distancing, Physical Activity, and COVID-19: Implications for Type 1 Diabetes Mellitus in Brazil. Int J Environ Res Public Health 2021;18:12819. [PMID: 34886545 DOI: 10.3390/ijerph182312819] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
125 Reshad RAI, Riana SH, Chowdhury MA, Moin AT, Miah F, Sarkar B, Jewel NA. Diabetes in COVID-19 patients: challenges and possible management strategies. Egypt J Bronchol 2021;15. [DOI: 10.1186/s43168-021-00099-2] [Reference Citation Analysis]
126 Fiorini G, Franchi M, Corrao G, Tritto R, Fadelli S, Rigamonti AE, Sartorio A, Cella SG. Effects of SARS-CoV-2 pandemic on follow-up and pharmacological treatment of chronic diseases in undocumented migrants. BMJNPH 2021;4:365-373. [DOI: 10.1136/bmjnph-2021-000274] [Reference Citation Analysis]
127 Berrajaa S, Berrichi S, Bouayed Z, Mezzeoui SE, Aftiss FZ, Bkiyar H, Abda N, Housni B. Diabetes as a predictive factor for severe form and high mortality risk of COVID-19: Retrospective cohort study of 188 cases. Ann Med Surg (Lond) 2021;72:103095. [PMID: 34840736 DOI: 10.1016/j.amsu.2021.103095] [Reference Citation Analysis]
128 Nurun Nabi A, Ebihara A. Diabetes and Renin-Angiotensin-Aldosterone System: Pathophysiology and Genetics. Renin-Angiotensin Aldosterone System 2021. [DOI: 10.5772/intechopen.97518] [Reference Citation Analysis]
129 Ephraim RKD, Duah E, Nkansah C, Amoah S, Fosu E, Afrifa J, Botchway F, Okyere P, Essien-Baidoo S, Mensah K, Serwaa D, Sakyi SA, Adoba P, Fondjo LA, Ninnoni JP, Aderoju YBG. Psychological impact of COVID-19 on diabetes mellitus patients in Cape Coast, Ghana: a cross-sectional study. Pan Afr Med J 2021;40:76. [PMID: 34804343 DOI: 10.11604/pamj.2021.40.76.26834] [Reference Citation Analysis]
130 Figueroa-Pizano MD, Campa-Mada AC, Carvajal-Millan E, Martinez-Robinson KG, Chu AR. The underlying mechanisms for severe COVID-19 progression in people with diabetes mellitus: a critical review. AIMS Public Health 2021;8:720-42. [PMID: 34786431 DOI: 10.3934/publichealth.2021057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
131 Bellido V, Pérez A. COVID-19 and Diabetes. J Clin Med 2021;10:5341. [PMID: 34830623 DOI: 10.3390/jcm10225341] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
132 Zubkin ML, Frolova NF, Kim IG, Ushakova AI, Usatiuk SS, Iskhakov RT, Diakova EN, Chervinko VI, Volodina EV, Tomilina NA, Kryukov EV. COVID-19 in haemodialysis patients: result analysis of the first year of the pandemic. Terapevticheskii arkhiv 2021;93:1325-33. [DOI: 10.26442/00403660.2021.11.201215] [Reference Citation Analysis]
133 Tilinca MC, Gliga MC, Varga A. The Pathophysiology and Management of Diabetic Ketoacidosis in COVID-19 Patients: A Literature Review. The Journal of Critical Care Medicine 2021;0. [DOI: 10.2478/jccm-2021-0024] [Reference Citation Analysis]
134 Khalili D, Varzandeh M. Triaging diabetes research in perplexed COVID-19 resources: Avoiding research waste through a corpus-based approach. J Res Med Sci 2021;26:83. [PMID: 34760000 DOI: 10.4103/jrms.JRMS_920_20] [Reference Citation Analysis]
135 Harbuwono DS, Handayani DOTL, Wahyuningsih ES, Supraptowati N, Ananda, Kurniawan F, Wafa S, Kristanti M, Pantoro NI, Sinto R, Kurniawan H, Rebekka, Tahapary DL. Impact of diabetes mellitus on COVID-19 clinical symptoms and mortality: Jakarta's COVID-19 epidemiological registry. Prim Care Diabetes 2021:S1751-9918(21)00192-3. [PMID: 34857490 DOI: 10.1016/j.pcd.2021.11.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
136 Bhardwaj R, Sharma A, Parasher A, Gupta H, Sahu S, Pal S. Rhino-Orbito-Cerebral Mucormycosis During the Second Wave of Covid-19: The Indian Scenario. Indian J Otolaryngol Head Neck Surg 2021;:1-6. [PMID: 34786356 DOI: 10.1007/s12070-021-02978-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
137 Lusher J, Cameron D. How to Manage Type 2 Diabetes Mellitus During the COVID-19 Pandemic: Let’s Hear the Patient’s Voice. EMJ Diabet 2021. [DOI: 10.33590/emjdiabet/21-00133] [Reference Citation Analysis]
138 Kukla M, Menżyk T, Dembiński M, Winiarski M, Garlicki A, Bociąga-Jasik M, Skonieczna M, Hudy D, Maziarz B, Kusnierz-Cabala B, Skladany L, Grgurevic I, Wójcik-Bugajska M, Grodzicki T, Stygar D, Rogula T. Anti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes. Sci Rep 2021;11:21514. [PMID: 34728695 DOI: 10.1038/s41598-021-00928-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
139 Drago C, Gatto A, Ruggeri M. Telemedicine as technoinnovation to tackle COVID-19: A bibliometric analysis. Technovation 2021. [DOI: 10.1016/j.technovation.2021.102417] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
140 Ouedraogo E, Allard L, Bihan H, Goupil de Bouillé J, Giroux-Leprieur B, Sutton A, Baudry C, Josse C, Didier M, Deutsch D, Rezgani I, Bouchaud O, Cosson E. The association of metabolic syndrome and COVID-19 deterioration. Nutr Metab Cardiovasc Dis 2021;31:3236-42. [PMID: 34629251 DOI: 10.1016/j.numecd.2021.08.036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
141 Zhan Q. Welcome to your new journal: Medical Review. Medical Review 2021;1:2-2. [DOI: 10.1515/mr-2021-0030] [Reference Citation Analysis]
142 Urano E, Okamura T, Ono C, Ueno S, Nagata S, Kamada H, Higuchi M, Furukawa M, Kamitani W, Matsuura Y, Kawaoka Y, Yasutomi Y. COVID-19 cynomolgus macaque model reflecting human COVID-19 pathological conditions. Proc Natl Acad Sci U S A 2021;118:e2104847118. [PMID: 34625475 DOI: 10.1073/pnas.2104847118] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
143 Ontiveros N, Becerril-Gaitan A, Llausas-Villarreal A, Gonzalez-Urquijo M, Paredes-Vazquez JG, Martínez-Resendez MF, Fabiani MA. Venous Thromboembolism in Hospitalized COVID-19 Patients Treated in a Single Academic Center in Mexico: A Case Series Study. Vasc Endovascular Surg 2021;:15385744211051495. [PMID: 34666570 DOI: 10.1177/15385744211051495] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
144 Bolesławska I, Błaszczyk-Bębenek E, Jagielski P, Jagielska A, Przysławski J. Nutritional behaviors of women and men in Poland during confinement related to the SARS-CoV-2 epidemic. Sci Rep 2021;11:19984. [PMID: 34620981 DOI: 10.1038/s41598-021-99561-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
145 Feng T, James A, Doumlele K, White S, Twardzik W, Zahid K, Sattar Z, Ukponmwan O, Nakeshbandi M, Chow L, Foronjy R. Procalcitonin Levels in COVID-19 Patients Are Strongly Associated with Mortality and ICU Acceptance in an Underserved, Inner City Population. Medicina (Kaunas) 2021;57:1070. [PMID: 34684107 DOI: 10.3390/medicina57101070] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
146 Sen S, Chakraborty R, Kalita P, Pathak MP. Diabetes mellitus and COVID-19: Understanding the association in light of current evidence. World J Clin Cases 2021; 9(28): 8327-8339 [PMID: 34754842 DOI: 10.12998/wjcc.v9.i28.8327] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
147 Pettus J, Skolnik N. Importance of diabetes management during the COVID-19 pandemic. Postgrad Med 2021;133:912-9. [PMID: 34602003 DOI: 10.1080/00325481.2021.1978704] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
148 Yin Y, Rohli KE, Shen P, Lu H, Liu Y, Dou Q, Zhang L, Kong X, Yang S, Jia P. The epidemiology, pathophysiological mechanisms, and management toward COVID-19 patients with Type 2 diabetes: A systematic review. Prim Care Diabetes 2021;15:899-909. [PMID: 34600859 DOI: 10.1016/j.pcd.2021.08.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
149 Xavier C, Rasu RS. Health Disparities of Coronavirus Disease 2019 in Texas, March-July 2020. South Med J 2021;114:649-56. [PMID: 34599344 DOI: 10.14423/SMJ.0000000000001308] [Reference Citation Analysis]
150 Wisnu Wardana VA, Rosyid AN. Inflammatory Mechanism and Clinical Implication of Asthma in COVID-19. Clin Med Insights Circ Respir Pulm Med 2021;15:11795484211042711. [PMID: 34594145 DOI: 10.1177/11795484211042711] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
151 Abdollahzadeh R, Shushizadeh MH, Barazandehrokh M, Choopani S, Azarnezhad A, Paknahad S, Pirhoushiaran M, Makani SZ, Yeganeh RZ, Al-Kateb A, Heidarzadehpilehrood R. Association of Vitamin D receptor gene polymorphisms and clinical/severe outcomes of COVID-19 patients. Infect Genet Evol 2021;96:105098. [PMID: 34610433 DOI: 10.1016/j.meegid.2021.105098] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
152 Muller M, Bulubas I, Vogel T. Les facteurs pronostiques dans la Covid-19. NPG Neurologie - Psychiatrie - Gériatrie 2021;21:304-312. [DOI: 10.1016/j.npg.2021.06.002] [Reference Citation Analysis]
153 Wang H, Yuan X, Wang J, Sun C, Wang G. Telemedicine maybe an effective solution for management of chronic disease during the COVID-19 epidemic. Prim Health Care Res Dev 2021;22:e48. [PMID: 34583801 DOI: 10.1017/S1463423621000517] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
154 Samuel W, Monjane NE. COMORBIDADES E CO-INFECÇÃO COMO FATORES DE RISCO ASSOCIADOS AO AGRAVAMENTO DE INFECÇÃO PELA COVID-19 EM PACIENTES ATENDIDOS NO CENTRO DE SAÚDE DE METANGULA, NO NORTE DE MOÇAMBIQUE. RECISATEC 2021;1:e1226. [DOI: 10.53612/recisatec.v1i2.26] [Reference Citation Analysis]
155 Yang K, Wen G, Wang J, Zhou S, Da W, Meng Y, Xue Y, Tao L. Complication and Sequelae of COVID-19: What Should We Pay Attention to in the Post-Epidemic Era. Front Immunol 2021;12:711741. [PMID: 34539642 DOI: 10.3389/fimmu.2021.711741] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
156 Eid RA, Attia AM, Hassan M, Shaker MA, Kamal MA. Demographic, clinical, and laboratory characteristics of patients with COVID-19 during the second and third waves of the pandemic in Egypt. J Infect Public Health 2021;14:1358-66. [PMID: 34511379 DOI: 10.1016/j.jiph.2021.08.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
157 Abbasi E, Mirzaei F, Tavilani H, Khodadadi I. Diabetes and COVID-19: Mechanism of pneumonia, treatment strategy and vaccine. Metabol Open 2021;11:100122. [PMID: 34514363 DOI: 10.1016/j.metop.2021.100122] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
158 Yu C, Helwig EJ. Role of rehabilitation amidst the COVID-19 pandemic: a review. J Transl Med 2021;19:376. [PMID: 34481486 DOI: 10.1186/s12967-021-03048-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
159 Sandoval-gallegos EM, Ramírez-moreno E, Vargas-mendoza N, Arias-rico J, Estrada-luna D, Cuevas-cancino JJ, Jiménez-sánchez RC, Flores-chávez OR, Baltazar-téllez RM, Morales-gonzález JA. Phytochemicals and Their Possible Mechanisms in Managing COVID-19 and Diabetes. Applied Sciences 2021;11:8163. [DOI: 10.3390/app11178163] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
160 Sorsa T, Sahni V, Buduneli N, Gupta S, Räisänen IT, Golub LM, Lee HM, Pätilä T, Bostanci N, Meurman J, Pärnänen P, Nwhator SO, Singla M, Gauba K. Active matrix metalloproteinase-8 (aMMP-8) point-of-care test (POCT) in the COVID-19 pandemic. Expert Rev Proteomics 2021;18:707-17. [PMID: 34468272 DOI: 10.1080/14789450.2021.1976151] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
161 Ratzki-Leewing AA, Ryan BL, Buchenberger JD, Dickens JW, Black JE, Harris SB. COVID-19 hinterland: surveilling the self-reported impacts of the pandemic on diabetes management in the USA (cross-sectional results of the iNPHORM study). BMJ Open 2021;11:e049782. [PMID: 34475174 DOI: 10.1136/bmjopen-2021-049782] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
162 Nong NTP, Hsu JL. Characteristics of Food Protein-Derived Antidiabetic Bioactive Peptides: A Literature Update. Int J Mol Sci 2021;22:9508. [PMID: 34502417 DOI: 10.3390/ijms22179508] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
163 Khan M, Singh GK, Abrar S, Ganeshan R, Morgan K, Harky A. Pharmacotherapeutic agents for the management of COVID-19 patients with preexisting cardiovascular disease. Expert Opin Pharmacother 2021;:1-20. [PMID: 34464223 DOI: 10.1080/14656566.2021.1960311] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
164 Arslan K, Baş S. COVID-19 and Diabetes - Prevalence and Prognosis: A Single-Center Experience. Turkish Journal of Diabetes and Obesity 2021;5:180-185. [DOI: 10.25048/tudod.904249] [Reference Citation Analysis]
165 Skrajnowska D, Brumer M, Kankowska S, Matysek M, Miazio N, Bobrowska-Korczak B. Covid 19: Diet Composition and Health. Nutrients 2021;13:2980. [PMID: 34578858 DOI: 10.3390/nu13092980] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
166 Goyal A, Mathew UE, Golla KK, Mannar V, Kubihal S, Gupta Y, Tandon N. A practical guidance on the use of intravenous insulin infusion for management of inpatient hyperglycemia: Intravenous Insulin Infusion for Management of Inpatient Hyperglycemia. Diabetes Metab Syndr 2021;15:102244. [PMID: 34425556 DOI: 10.1016/j.dsx.2021.102244] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
167 Caycho-Rodríguez T, Vilca LW, Corrales-Reyes IE, Hernández-García F, Pérez AP, Quintana PG, Pérez García ER, Lazo Herrera LA, White M. COVID-19 contagion concern scale (PRE-COVID-19): Validation in Cuban patients with type 2 diabetes. Diabetes Metab Syndr 2021;15:102245. [PMID: 34416467 DOI: 10.1016/j.dsx.2021.102245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
168 Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis 2021;21:855. [PMID: 34418980 DOI: 10.1186/s12879-021-06536-3] [Cited by in Crossref: 92] [Cited by in F6Publishing: 109] [Article Influence: 46.0] [Reference Citation Analysis]
169 Jayaswal SK, Singh S, Malik PS, Venigalla SK, Gupta P, Samaga SN, Hota RN, Bhatia SS, Gupta I. Detrimental effect of diabetes and hypertension on the severity and mortality of COVID-19 infection: A multi-center case-control study from India. Diabetes Metab Syndr 2021;15:102248. [PMID: 34412000 DOI: 10.1016/j.dsx.2021.102248] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
170 Mistry S, Gouripeddi R, Facelli JC, Facelli JC. Data-driven identification of temporal glucose patterns in a large cohort of nondiabetic patients with COVID-19 using time-series clustering. JAMIA Open 2021;4:ooab063. [PMID: 34409266 DOI: 10.1093/jamiaopen/ooab063] [Reference Citation Analysis]
171 Bonansea TCP, Santos LPD, Zintl K, Souza ACDS. Diabetes in the COVID-19 pandemic era. Rev Assoc Med Bras (1992) 2021;67Suppl 1:157-62. [PMID: 34406303 DOI: 10.1590/1806-9282.67.Suppl1.20200814] [Reference Citation Analysis]
172 Vanderboom PM, Mun DG, Madugundu AK, Mangalaparthi KK, Saraswat M, Garapati K, Chakraborty R, Ebihara H, Sun J, Pandey A. Proteomic Signature of Host Response to SARS-CoV-2 Infection in the Nasopharynx. Mol Cell Proteomics 2021;20:100134. [PMID: 34400346 DOI: 10.1016/j.mcpro.2021.100134] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
173 Huang D, Miao H, Zhang Z, Yang Y, Zhang L, Lure FYM, Wang Z, Jaeger S, Guo L, Xu T, Liu J. Longitudinal changes of laboratory measurements after discharged from hospital in 268 COVID-19 pneumonia patients. J Xray Sci Technol 2021. [PMID: 34397444 DOI: 10.3233/XST-210920] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
174 Khanam R. Bidirectional Relationship between COVID-19 and Diabetes: Role of Renin-Angiotensin-Aldosterone System and Drugs Modulating It. J Pharm Bioallied Sci 2021;13:149-54. [PMID: 34349473 DOI: 10.4103/jpbs.JPBS_508_20] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
175 Cai Z, Yang Y, Zhang J. Obesity is associated with severe disease and mortality in patients with coronavirus disease 2019 (COVID-19): a meta-analysis. BMC Public Health 2021;21:1505. [PMID: 34348687 DOI: 10.1186/s12889-021-11546-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 16.5] [Reference Citation Analysis]
176 Varnell C, Harshman LA, Smith L, Liu C, Chen S, Al‐akash S, Barletta G, Belsha C, Brakeman P, Chaudhuri A, Fadakar P, Garro R, Gluck C, Goebel J, Kershaw D, Matossian D, Nailescu C, Patel HP, Pruette C, Ranabothu S, Rodig N, Smith J, Sebestyen Vansickle J, Weng P, Danziger‐isakov L, Hooper DK, Seifert M. COVID‐19 in pediatric kidney transplantation: The Improving Renal Outcomes Collaborative. Am J Transplant 2021;21:2740-8. [DOI: 10.1111/ajt.16501] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
177 Varnell C Jr, Harshman LA, Smith L, Liu C, Chen S, Al-Akash S, Barletta GM, Belsha C, Brakeman P, Chaudhuri A, Fadakar P, Garro R, Gluck C, Goebel J, Kershaw D, Matossian D, Nailescu C, Patel HP, Pruette C, Ranabothu S, Rodig N, Smith J, Sebestyen VanSickle J, Weng P, Danziger-Isakov L, Hooper DK, Seifert M. COVID-19 in pediatric kidney transplantation: The Improving Renal Outcomes Collaborative. Am J Transplant 2021;21:2740-8. [PMID: 33452854 DOI: 10.1111/ajt.16501] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
178 Houdre J, Laaraj F, Sorrel Dejerine A, Brunetti N, Neiss M, Vétillard A, Mary M, Simon P, Colas M, Houenou-quenum N, Souques C, Trivalle C, Guichardon M, Collarino R, Baudouin E, Duron E. Caractéristiques et mortalité des patients gériatriques infectés au Sars-CoV2 : description et comparaison des patients hospitalisés en unité dédiée COVID et de ceux en unités Alzheimer. NPG Neurologie - Psychiatrie - Gériatrie 2021;21:255-261. [DOI: 10.1016/j.npg.2021.02.001] [Reference Citation Analysis]
179 Stevens JS, Bogun MM, McMahon DJ, Zucker J, Kurlansky P, Mohan S, Yin MT, Nickolas TL, Pajvani UB. Diabetic ketoacidosis and mortality in COVID-19 infection. Diabetes Metab 2021;47:101267. [PMID: 34332112 DOI: 10.1016/j.diabet.2021.101267] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
180 Renaldi FS, Sauriasari R, Riyadina W. Pandemic 2020: Economic pressure and evaluation of a primary health care innovation programme for type 2 diabetes mellitus treatment. Pharm Educ 2021;21:132-142. [DOI: 10.46542/pe.2021.212.132142] [Reference Citation Analysis]
181 Robert AA, Al Saeed A, Al Dawish MA. COVID-19 among people with diabetes mellitus in Saudi Arabia: Current situation and new perspectives. Diabetes Metab Syndr 2021;15:102231. [PMID: 34330072 DOI: 10.1016/j.dsx.2021.102231] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
182 Pothiawala S. Mitigating the Emerging Threat of Mucormycosis in COVID-19. Proceedings of Singapore Healthcare. [DOI: 10.1177/20101058211034951] [Reference Citation Analysis]
183 Choi YJ, Park JY, Lee HS, Suh J, Song JY, Byun MK, Cho JH, Kim HJ, Park HJ. Variable effects of underlying diseases on the prognosis of patients with COVID-19. PLoS One 2021;16:e0254258. [PMID: 34280188 DOI: 10.1371/journal.pone.0254258] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
184 Bielka W, Przezak A, Pawlik A. Therapy of Type 2 Diabetes in Patients with SARS-CoV-2 Infection. Int J Mol Sci 2021;22:7605. [PMID: 34299225 DOI: 10.3390/ijms22147605] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
185 Rahman MR, Islam T, Shahjaman M, Islam MR, Lombardo SD, Bramanti P, Ciurleo R, Bramanti A, Tchorbanov A, Fisicaro F, Fagone P, Nicoletti F, Pennisi M. Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis. Brief Bioinform 2021:bbab262. [PMID: 34260684 DOI: 10.1093/bib/bbab262] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
186 Girgis SA, Hafez HM, Elarab HE, Sherif B, Sabry MH, Afifi I, Hassan FE, Reda A, Elsayed S, Mahmoud A, Habeb P, Habil IS, Hussein RS, Mossad IM, Mansour O, Omar A, Saleh AM, El-Meteini M. SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital. PLoS One 2021;16:e0254581. [PMID: 34265021 DOI: 10.1371/journal.pone.0254581] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
187 Estedlal A, Jeddi M, Heydari ST, Jahromi MG, Dabbaghmanesh MH. Impacts of diabetes mellitus on clinical and para-clinical parameters among COVID-19 patients. J Diabetes Metab Disord 2021;:1-9. [PMID: 34277497 DOI: 10.1007/s40200-021-00844-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
188 Siva Ganesa Karthikeyan R, Rameshkumar G, Gowri Priya C, Lalitha P, Devi R, Iswarya M, Ravindran RD. Seroprevalence of SARS-CoV-2 specific IgG antibodies among eye care workers in South India. Indian J Med Microbiol 2021:S0255-0857(21)04165-7. [PMID: 34253410 DOI: 10.1016/j.ijmmb.2021.06.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
189 Shimmel A, Shaikhouni S, Mariani L. Current Understanding of Clinical Manifestations of COVID-19 in Glomerular Disease. Glomerular Dis 2021;1:250-64. [DOI: 10.1159/000518276] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
190 Verma AK, Beg MMA, Bhatt D, Dev K, Alsahli MA, Rahmani AH, Goyal Y. Assessment and Management of Diabetic Patients During the COVID-19 Pandemic. Diabetes Metab Syndr Obes 2021;14:3131-46. [PMID: 34262317 DOI: 10.2147/DMSO.S285614] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
191 Brojakowska A, Eskandari A, Bisserier M, Bander J, Garikipati VNS, Hadri L, Goukassian DA, Fish KM. Comorbidities, sequelae, blood biomarkers and their associated clinical outcomes in the Mount Sinai Health System COVID-19 patients. PLoS One 2021;16:e0253660. [PMID: 34228746 DOI: 10.1371/journal.pone.0253660] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
192 Boutin S, Hildebrand D, Boulant S, Kreuter M, Rüter J, Pallerla SR, Velavan TP, Nurjadi D. Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs. Cell Mol Life Sci 2021;78:5953-76. [PMID: 34223911 DOI: 10.1007/s00018-021-03889-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 6.5] [Reference Citation Analysis]
193 Patel KHK, Li X, Quint JK, Ware JS, Peters NS, Ng FS. Increasing adiposity and the presence of cardiometabolic morbidity is associated with increased Covid-19-related mortality: results from the UK Biobank. BMC Endocr Disord 2021;21:144. [PMID: 34217276 DOI: 10.1186/s12902-021-00805-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
194 Tinti D, Savastio S, Grosso C, De Donno V, Trada M, Nugnes M, Bertelli E, Franceschi L, Marchisio M, Pozzi E, Tappi E, Felici E, De Sanctis L, Rabbone I. Impact of lockdown during COVID-19 emergency on glucose metrics of children and adolescents with type 1 diabetes in Piedmont, Italy. Acta Diabetol 2021;58:959-61. [PMID: 33721077 DOI: 10.1007/s00592-021-01702-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
195 Olutomilola EO. A review of raw plantain size reduction. Scientific African 2021;12:e00773. [DOI: 10.1016/j.sciaf.2021.e00773] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
196 Conti V, Corbi G, Sellitto C, Sabbatino F, Maci C, Bertini N, De Bellis E, Iuliano A, Davinelli S, Pagliano P, Filippelli A. Effect of Tocilizumab in Reducing the Mortality Rate in COVID-19 Patients: A Systematic Review with Meta-Analysis. J Pers Med 2021;11:628. [PMID: 34357095 DOI: 10.3390/jpm11070628] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
197 Cyranka K, Dudek D, Małecki MT, Matejko B, Klupa T. Psychological Crisis Intervention for COVID-19 Lockdown Stress in Patients With Type 1 Diabetes Mellitus: Survey Study and Qualitative Analysis. JMIR Ment Health 2021;8:e28097. [PMID: 33852411 DOI: 10.2196/28097] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
198 Pakdel F. How COVID-19 Impacted on Rhino-Orbital-Cerebral Mucormycosis. IJCEO 2021;7:257-258. [DOI: 10.18231/j.ijceo.2021.054] [Reference Citation Analysis]
199 Vivek V, Karuna V, Singh R, Gupta P, Verma N, Rathi M. Co-morbidities: Prevalence and evaluation of risk with COVID-19 (SARS CoV2) infection: A retrospective study. JDPO 2021;6:119-126. [DOI: 10.18231/j.jdpo.2021.026] [Reference Citation Analysis]
200 Sharif N, Opu RR, Ahmed SN, Sarkar MK, Jaheen R, Daullah MU, Khan S, Mubin M, Rahman H, Islam F, Haque N, Islam S, Khan FB, Haque N, Ayman U, Shohael AM, Dey SK, Talukder AA. Prevalence and impact of comorbidities on disease prognosis among patients with COVID-19 in Bangladesh: A nationwide study amid the second wave. Diabetes Metab Syndr 2021;15:102148. [PMID: 34186349 DOI: 10.1016/j.dsx.2021.05.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
201 Sujan MSH, Tasnim R, Islam MS, Ferdous MZ, Apu MAR, Musfique MM, Pardhan S. COVID-19-specific diabetes worries amongst diabetic patients: The role of social support and other co-variates. Prim Care Diabetes 2021:S1751-9918(21)00113-3. [PMID: 34210639 DOI: 10.1016/j.pcd.2021.06.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
202 Unnikrishnan R, Misra A. Diabetes and COVID19: a bidirectional relationship. Eur J Clin Nutr 2021;75:1332-6. [PMID: 34163019 DOI: 10.1038/s41430-021-00961-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
203 Unnikrishnan R, Misra A. Diabetes and COVID19: a bidirectional relationship. Nutr Diabetes 2021;11:21. [PMID: 34168110 DOI: 10.1038/s41387-021-00163-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
204 Pikovsky M, Tan MY, Ahmed A, Sykes L, Agha-Jaffar R, Yu CKH. Euglycaemic ketoacidosis in pregnant women with COVID-19: two case reports. BMC Pregnancy Childbirth 2021;21:427. [PMID: 34134652 DOI: 10.1186/s12884-021-03928-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
205 Pikovsky M, Tan MY, Ahmed A, Sykes L, Agha-Jaffar R, Yu CKH. Euglycaemic ketoacidosis in pregnant women with COVID-19: two case reports. BMC Pregnancy Childbirth 2021;21:427. [PMID: 34134652 DOI: 10.1186/s12884-021-03928-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
206 Zhou L, Seesaghur HN, Akhtar N, Boolakee J, Pratt CB. A Citywide 'Virus Testing': Chinese Government's Response to Preventing and Controlling the Second Outbreak of SARS-CoV-2. Front Public Health 2021;9:601592. [PMID: 34222164 DOI: 10.3389/fpubh.2021.601592] [Reference Citation Analysis]
207 Piani F, Reinicke T, Borghi C, Tommerdahl KL, Cara-Fuentes G, Johnson RJ, Bjornstad P. Acute Kidney Injury in Pediatric Diabetic Kidney Disease. Front Pediatr 2021;9:668033. [PMID: 34211943 DOI: 10.3389/fped.2021.668033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
208 Aitbaev K, Mamutova S, Murkamilov I, Fomin V, Kudaibergenova I, Murkamilova Z, Yusupov F. Metformin in COVID-19 Therapy in Patients with Diabetes Mellitus: Benefit or Harm? BSP 2021;7:222-234. [DOI: 10.33619/2414-2948/67/25] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
209 Aref ZF, Bazeed SEES, Hassan MH, Hassan AS, Rashad A, Hassan RG, Abdelmaksoud AA. Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19. Int J Nanomedicine 2021;16:4063-72. [PMID: 34163159 DOI: 10.2147/IJN.S313093] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
210 Bhatt KP, Quinonez J, Patel A, Patel M, Mohamed A, Aziz MA, Venkataramani D, Zohora F, Hange N, Awad D, Mehta I, Domingo PIM, Jamil N, Kandi SR, Thevuthasan S, Khawaja UA, Baskaran D, Banks L, Michel G, Sanchez-gonzalez M. COVID-19 Pathophysiology and Clinical Effects on Multiple Organ Systems - A Narrative Review. Int Ann Sci 2021;10:151-167. [DOI: 10.21467/ias.10.1.151-167] [Reference Citation Analysis]
211 Rafiq K, Nesar S, Anser H, Leghari QU, Hassan A, Rizvi A, Raza A, Saify ZS. Self-Medication in the COVID-19 Pandemic: Survival of the Fittest. Disaster Med Public Health Prep 2021;:1-5. [PMID: 34099083 DOI: 10.1017/dmp.2021.173] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
212 Nikoloski Z, Alqunaibet AM, Alfawaz RA, Almudarra SS, Herbst CH, El-Saharty S, Alsukait R, Algwizani A. Covid-19 and non-communicable diseases: evidence from a systematic literature review. BMC Public Health 2021;21:1068. [PMID: 34090396 DOI: 10.1186/s12889-021-11116-w] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 11.0] [Reference Citation Analysis]
213 Ko JY, Danielson ML, Town M, Derado G, Greenlund KJ, Kirley PD, Alden NB, Yousey-Hindes K, Anderson EJ, Ryan PA, Kim S, Lynfield R, Torres SM, Barney GR, Bennett NM, Sutton M, Talbot HK, Hill M, Hall AJ, Fry AM, Garg S, Kim L; COVID-NET Surveillance Team. Risk Factors for Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization: COVID-19-Associated Hospitalization Surveillance Network and Behavioral Risk Factor Surveillance System. Clin Infect Dis 2021;72:e695-703. [PMID: 32945846 DOI: 10.1093/cid/ciaa1419] [Cited by in Crossref: 113] [Cited by in F6Publishing: 146] [Article Influence: 56.5] [Reference Citation Analysis]
214 Chellappan A, Susan Jacob H, R C, Lalwani CS, S Nair A. “SELF-MEDICATION FOR PREVENTION OF COVID-19: A CROSSSECTIONAL ONLINE SURVEY AMONG THE GENERAL PUBLIC IN SOUTH INDIA”. IJAR 2021. [DOI: 10.36106/ijar/9209352] [Reference Citation Analysis]
215 Silverio R, Gonçalves DC, Andrade MF, Seelaender M. Coronavirus Disease 2019 (COVID-19) and Nutritional Status: The Missing Link? Adv Nutr 2021;12:682-92. [PMID: 32975565 DOI: 10.1093/advances/nmaa125] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 16.0] [Reference Citation Analysis]
216 Bajka A, Wiest MRJ, Hamann T, Toro MD, Zweifel SA. Assessment of Patients' Confidence Regarding a New Triage Concept in a Medical Retina Clinic during the First COVID-19 Outbreak. Int J Environ Res Public Health 2021;18:5846. [PMID: 34072435 DOI: 10.3390/ijerph18115846] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
217 Alves M, Fernandes MA, Bahat G, Benetos A, Clemente H, Grodzicki T, Martínez-Sellés M, Mattace-Raso F, Rajkumar C, Ungar A, Werner N, Strandberg TE; EuGMS Special Interest Group inCardiovascular Medicine (Chairpersons A. Ungar and A. Benetos). Protecting older patients with cardiovascular diseases from COVID-19 complications using current medications. Eur Geriatr Med 2021;12:725-39. [PMID: 34031865 DOI: 10.1007/s41999-021-00504-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
218 Raghavan A, Nanditha A, Satheesh K, Susairaj P, Vinitha R, Chandrasekaran S, Palaniappan T, Thillai Vallal S, Subair Khan A, Snehalatha C, Ramachandran A. Profile and prognosis of patients hospitalized for COVID-19 virus infection with and without diabetes - An observational study from South India. Diabetes Metab Syndr 2021;15:102143. [PMID: 34186345 DOI: 10.1016/j.dsx.2021.05.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
219 Nandy K, Dhanwate A, Salunke AA, Tank T, Patel K, Kumar Pathak S, Menon P, Upadhay S, Shanmugasundaram S, Bhirud C, Sharma A, Patil P, Sonawane S, Pandya S. A community response survey on an ABCD scoring system for patient's self assessment with symptoms of COVID-19. Diabetes Metab Syndr 2021;15:102141. [PMID: 34186368 DOI: 10.1016/j.dsx.2021.05.014] [Reference Citation Analysis]
220 Lamptey R, Engmann St ST, Asante B, Yorke E, Mensah YB, Akoriyea SK, Owoo C, Lawson HJ. Atypical presentation of COVID-19 in a patient with type 2 diabetes at an urban primary care facility in Accra, Ghana. Ghana Med J 2020;54:117-20. [PMID: 33976452 DOI: 10.4314/gmj.v54i4s.19] [Reference Citation Analysis]
221 Mishra D, Dey CS. Type-2 diabetes, a co-morbidity in Covid-19: does insulin signaling matter? Biochem Soc Trans 2021;49:987-95. [PMID: 33666220 DOI: 10.1042/BST20201062] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
222 Sánchez Díaz JS, Peniche Moguel KG, González Escudero EA, Del Carpio Orantes L, Monares Zepeda E, Perez Nieto OR, Zamarron Lopez EI, Deloya Tomas E, Estrada Gonzalez FE, Díaz Torres J, Escarraman Martinez D, Guerrero Gutierrez MA. Glycosylated hemoglobin as a predictor of mortality in severe pneumonia by COVID-19. Expert Rev Respir Med 2021;15:1077-82. [PMID: 33955309 DOI: 10.1080/17476348.2021.1926988] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
223 Shin EK, Choi HY, Hayes N. The anatomy of COVID-19 comorbidity networks among hospitalized Korean patients. Epidemiol Health 2021;43:e2021035. [PMID: 33971700 DOI: 10.4178/epih.e2021035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
224 Kostova D, Richter P, Van Vliet G, Mahar M, Moolenaar RL. The Role of Noncommunicable Diseases in the Pursuit of Global Health Security. Health Secur 2021;19:288-301. [PMID: 33961498 DOI: 10.1089/hs.2020.0121] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
225 Afshar-Oromieh A, Prosch H, Schaefer-Prokop C, Bohn KP, Alberts I, Mingels C, Thurnher M, Cumming P, Shi K, Peters A, Geleff S, Lan X, Wang F, Huber A, Gräni C, Heverhagen JT, Rominger A, Fontanellaz M, Schöder H, Christe A, Mougiakakou S, Ebner L. A comprehensive review of imaging findings in COVID-19 - status in early 2021. Eur J Nucl Med Mol Imaging 2021;48:2500-24. [PMID: 33932183 DOI: 10.1007/s00259-021-05375-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
226 Antunez Muiños PJ, López Otero D, Amat-Santos IJ, López País J, Aparisi A, Cacho Antonio CE, Catalá P, González Ferrero T, Cabezón G, Otero García O, Gil JF, Pérez Poza M, Candela J, Rojas G, Jiménez Ramos V, Veras C, San Román JA, González-Juanatey JR. The COVID-19 lab score: an accurate dynamic tool to predict in-hospital outcomes in COVID-19 patients. Sci Rep 2021;11:9361. [PMID: 33931677 DOI: 10.1038/s41598-021-88679-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
227 Shoily SS, Ahsan T, Fatema K, Sajib AA. Disparities in COVID-19 severities and casualties across ethnic groups around the globe and patterns of ACE2 and PIR variants. Infect Genet Evol 2021;92:104888. [PMID: 33933634 DOI: 10.1016/j.meegid.2021.104888] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
228 George JA, Khoza S, Mayne E, Dlamini S, Kone N, Jassat W, Chetty K, Centner C, Pillay T, Maphayi MR, Mabuza DV, Maposa I, Cassim N. Sentinel seroprevalence of SARS-CoV-2 in the Gauteng province, South Africa August to October 2020.. [DOI: 10.1101/2021.04.27.21256099] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
229 Patrício A, Costa RS, Henriques R. Predictability of COVID-19 Hospitalizations, Intensive Care Unit Admissions, and Respiratory Assistance in Portugal: Longitudinal Cohort Study. J Med Internet Res 2021;23:e26075. [PMID: 33835931 DOI: 10.2196/26075] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
230 Tekcan Şanlı DE, Yıldırım D. A new imaging sign in COVID-19 pneumonia: vascular changes and their correlation with clinical severity of the disease. Diagn Interv Radiol 2021;27:172-80. [PMID: 33044171 DOI: 10.5152/dir.2020.20346] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
231 Lopez-Castaneda S, García-Larragoiti N, Cano-Mendez A, Blancas-Ayala K, Damian-Vázquez G, Perez-Medina AI, Chora-Hernández LD, Arean-Martínez C, Viveros-Sandoval ME. Inflammatory and Prothrombotic Biomarkers Associated With the Severity of COVID-19 Infection. Clin Appl Thromb Hemost 2021;27:1076029621999099. [PMID: 33835872 DOI: 10.1177/1076029621999099] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
232 Nakano H, Shiina K, Tomiyama H. Cardiovascular Outcomes in the Acute Phase of COVID-19. Int J Mol Sci 2021;22:4071. [PMID: 33920790 DOI: 10.3390/ijms22084071] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
233 John TM, Jacob CN, Kontoyiannis DP. When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis. J Fungi (Basel) 2021;7:298. [PMID: 33920755 DOI: 10.3390/jof7040298] [Cited by in Crossref: 198] [Cited by in F6Publishing: 217] [Article Influence: 99.0] [Reference Citation Analysis]
234 Atergeleh HJ, Emamian MH, Goli S, Rohani-rasaf M, Hashemi H, Fotouhi A. The risk factors of COVID-19 in a longitudinal population-based study.. [DOI: 10.1101/2021.04.12.21255369] [Reference Citation Analysis]
235 Faghri PD, Dobson M, Landsbergis P, Schnall PL. COVID-19 Pandemic: What Has Work Got to Do With It? J Occup Environ Med 2021;63:e245-9. [PMID: 33560072 DOI: 10.1097/JOM.0000000000002154] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
236 K Y, A V L, Pujari CG, Poornima RN. COVID with Diabetic Ketoacidosis: Intriguer or Consequence. Indian J Pediatr 2021;88:599. [PMID: 33825132 DOI: 10.1007/s12098-021-03678-9] [Reference Citation Analysis]
237 Gomez JMD, Du-Fay-de-Lavallaz JM, Fugar S, Sarau A, Simmons JA, Clark B, Sanghani RM, Aggarwal NT, Williams KA, Doukky R, Volgman AS. Sex Differences in COVID-19 Hospitalization and Mortality. J Womens Health (Larchmt) 2021;30:646-53. [PMID: 33826864 DOI: 10.1089/jwh.2020.8948] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 17.5] [Reference Citation Analysis]
238 Ricchio M, Tassone B, Pelle MC, Mazzitelli M, Serapide F, Fusco P, Lionello R, Cancelliere A, Procopio G, Lio E, Trecarichi EM, Torti C, Irace C. Characteristics, Management, and Outcomes of Elderly Patients with Diabetes in a Covid-19 Unit: Lessons Learned from a Pilot Study. Medicina (Kaunas) 2021;57:341. [PMID: 33916210 DOI: 10.3390/medicina57040341] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
239 Corrao S, Pinelli K, Vacca M, Raspanti M, Argano C. Type 2 Diabetes Mellitus and COVID-19: A Narrative Review. Front Endocrinol (Lausanne) 2021;12:609470. [PMID: 33868163 DOI: 10.3389/fendo.2021.609470] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 15.5] [Reference Citation Analysis]
240 Khunti K, Knighton P, Zaccardi F, Bakhai C, Barron E, Holman N, Kar P, Meace C, Sattar N, Sharp S, Wareham NJ, Weaver A, Woch E, Young B, Valabhji J. Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England. Lancet Diabetes Endocrinol 2021;9:293-303. [PMID: 33798464 DOI: 10.1016/S2213-8587(21)00050-4] [Cited by in Crossref: 72] [Cited by in F6Publishing: 81] [Article Influence: 36.0] [Reference Citation Analysis]
241 Sarici A, Kirici Berber N, Çağaşar O, Biçim S, Çağan F, Ulutaş Ö, Gözükara H, Yakupoğullari Y, Berber İ. The impact of laboratory features and comorbidities on the prognosis of patients with Covid-19. Journal of Health Sciences and Medicine 2021;4:142-146. [DOI: 10.32322/jhsm.839303] [Reference Citation Analysis]
242 Zangiabadian M, Nejadghaderi SA, Zahmatkesh MM, Hajikhani B, Mirsaeidi M, Nasiri MJ. The Efficacy and Potential Mechanisms of Metformin in the Treatment of COVID-19 in the Diabetics: A Systematic Review. Front Endocrinol (Lausanne) 2021;12:645194. [PMID: 33815295 DOI: 10.3389/fendo.2021.645194] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 12.0] [Reference Citation Analysis]
243 Bumiller-Bini V, de Freitas Oliveira-Toré C, Carvalho TM, Kretzschmar GC, Gonçalves LB, Alencar NM, Gasparetto Filho MA, Beltrame MH, Winter Boldt AB. MASPs at the crossroad between the complement and the coagulation cascades - the case for COVID-19. Genet Mol Biol 2021;44:e20200199. [PMID: 33729332 DOI: 10.1590/1678-4685-GMB-2020-0199] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
244 Viswanathan V, Puvvula A, Jamthikar AD, Saba L, Johri AM, Kotsis V, Khanna NN, Dhanjil SK, Majhail M, Misra DP, Agarwal V, Kitas GD, Sharma AM, Kolluri R, Naidu S, Suri JS. Bidirectional link between diabetes mellitus and coronavirus disease 2019 leading to cardiovascular disease: A narrative review. World J Diabetes 2021; 12(3): 215-237 [PMID: 33758644 DOI: 10.4239/wjd.v12.i3.215] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 24] [Article Influence: 13.0] [Reference Citation Analysis]
245 Sathish T, Chandrika Anton M. Newly diagnosed diabetes in patients with mild to moderate COVID-19. Diabetes Metab Syndr 2021;15:569-71. [PMID: 33706188 DOI: 10.1016/j.dsx.2021.02.034] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
246 Hozhabr JA, Emamian MH, Goli S, Rohani-rasaf M, Hashemi H, Fotouhi A. The risk factors of COVID-19 in 50–74 years old people: a longitudinal population-based study. Epidemiologic Methods 2021;10. [DOI: 10.1515/em-2021-0024] [Reference Citation Analysis]
247 Abdel-Moneim A, Hosni A. Insights into the possible impact of COVID-19 on the endocrine system. Arch Physiol Biochem 2021;:1-9. [PMID: 33653188 DOI: 10.1080/13813455.2021.1890131] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
248 Bachache LN, Hasan JA, Al-neami AQ. Acousto-optic Design to Measure Glucose Level for Diabetic Patients Non-invasively. J Phys : Conf Ser 2021;1818:012147. [DOI: 10.1088/1742-6596/1818/1/012147] [Reference Citation Analysis]
249 Stewart M. Sick day advice for people with diabetes. Practice Nursing 2021;32:S10-S13. [DOI: 10.12968/pnur.2021.32.sup3.s10] [Reference Citation Analysis]
250 Triggle CR, Bansal D, Ding H, Islam MM, Farag EABA, Hadi HA, Sultan AA. A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic. Front Immunol 2021;12:631139. [PMID: 33717166 DOI: 10.3389/fimmu.2021.631139] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 33.0] [Reference Citation Analysis]
251 Hussain M, Iltaf S Sr, Salman S Sr, Ghuman F, Abbas S, Fatima M. Frequency of Comorbidities in Admitting COVID-19 Pneumonia Patients in a Tertiary Care Setup: An Observational Study. Cureus 2021;13:e13546. [PMID: 33815969 DOI: 10.7759/cureus.13546] [Reference Citation Analysis]
252 Giri R, Kumar A, Saini M, Sharma RK. Living with the virus: Infection and epidemiology of COVID-19 in hotspot area of India. J Public Aff 2021;:e2651. [PMID: 33786027 DOI: 10.1002/pa.2651] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
253 Demidova TY, Lobanova KG, Perekhodov SN, Antsiferov MB, Oynotkinova OS. Clinical and laboratory characteristics of patients with COVID-19 and concomitant type 2 diabetes. Cardiovasc Ther Prev 2021;20:2750. [DOI: 10.15829/1728-8800-2021-2750] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
254 Horrell LN, Hayes S, Herbert LB, MacTurk K, Lawhon L, Valle CG, Bhowmick A. Telemedicine Use and Health-Related Concerns of Patients With Chronic Conditions During COVID-19: Survey of Members of Online Health Communities. J Med Internet Res 2021;23:e23795. [PMID: 33539307 DOI: 10.2196/23795] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 11.5] [Reference Citation Analysis]
255 Hajjar LA, Costa IBSDS, Rizk SI, Biselli B, Gomes BR, Bittar CS, de Oliveira GQ, de Almeida JP, de Oliveira Bello MV, Garzillo C, Leme AC, Elena M, Val F, de Almeida Lopes M, Lacerda MVG, Ramires JAF, Kalil Filho R, Teboul JL, Landoni G. Intensive care management of patients with COVID-19: a practical approach. Ann Intensive Care 2021;11:36. [PMID: 33604873 DOI: 10.1186/s13613-021-00820-w] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 17.5] [Reference Citation Analysis]
256 Derruau S, Bouchet J, Nassif A, Baudet A, Yasukawa K, Lorimier S, Prêcheur I, Bloch-Zupan A, Pellat B, Chardin H, Jung S, On Behalf Of Task Force Covid-Collège National des EnseignantS En Biologie Orale Cnesbo-France. COVID-19 and Dentistry in 72 Questions: An Overview of the Literature. J Clin Med 2021;10:779. [PMID: 33669185 DOI: 10.3390/jcm10040779] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
257 Baril-Tremblay D, Marlats C, Ménager L. Self-isolation. J Math Econ 2021;93:102483. [PMID: 33583995 DOI: 10.1016/j.jmateco.2021.102483] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
258 Bolouri H, Speake C, Skibinski D, Long SA, Hocking AM, Campbell DJ, Hamerman JA, Malhotra U, Buckner JH; Benaroya Research Institute COVID-19 Research Team. The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity. J Clin Invest 2021;131:143648. [PMID: 33529167 DOI: 10.1172/JCI143648] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
259 Badrah M, Riad A, Kassem I, Boccuzzi M, Klugar M. Craniofacial pain in COVID-19 patients with diabetes mellitus: Clinical and laboratory description of 21 cases. J Med Virol 2021;93:2616-9. [PMID: 33570190 DOI: 10.1002/jmv.26866] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
260 Shestakova MV, Kononenko IV, Kalmykova ZA, Zheleznyakova AV, Mokrysheva NG. High level of glycated hemoglobin (HbA<sub>1c</sub>) in patients with COVID-19 is a marker of the severity of the infection but not an indicator of previous diabetes mellitus. Diabetes mellitus 2021;23:504-513. [DOI: 10.14341/dm12702] [Reference Citation Analysis]
261 Pham Q, Gamble A, Hearn J, Cafazzo JA. The Need for Ethnoracial Equity in Artificial Intelligence for Diabetes Management: Review and Recommendations. J Med Internet Res 2021;23:e22320. [PMID: 33565982 DOI: 10.2196/22320] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
262 Gupta Y, Goyal A, Kubihal S, Golla KK, Tandon N. A guidance on diagnosis and management of hyperglycemia at COVID care facilities in India. Diabetes Metab Syndr 2021;15:407-13. [PMID: 33581594 DOI: 10.1016/j.dsx.2021.01.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
263 Mazereel V, Van Assche K, Detraux J, De Hert M. COVID-19 vaccination for people with severe mental illness: why, what, and how? Lancet Psychiatry 2021;8:444-50. [PMID: 33548184 DOI: 10.1016/S2215-0366(20)30564-2] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 33.0] [Reference Citation Analysis]
264 Ergun-Longmire B, Clemente E, Vining-Maravolo P, Roberts C, Buth K, Greydanus DE. Diabetes education in pediatrics: How to survive diabetes. Dis Mon 2021;67:101153. [PMID: 33541707 DOI: 10.1016/j.disamonth.2021.101153] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
265 Nurwati I, Huda KN. Acupuncture Treatment for Coronavirus Disease 2019: A Review Article. Medical Acupuncture 2021;33:45-8. [DOI: 10.1089/acu.2020.1473] [Reference Citation Analysis]
266 Savant S, Srinivasan S, Kruthiventi AK. Potential Nutraceuticals for COVID-19. NDS 2021;Volume 13:25-51. [DOI: 10.2147/nds.s294231] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
267 Bajgain KT, Badal S, Bajgain BB, Santana MJ. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature. Am J Infect Control 2021;49:238-46. [PMID: 32659414 DOI: 10.1016/j.ajic.2020.06.213] [Cited by in Crossref: 121] [Cited by in F6Publishing: 140] [Article Influence: 60.5] [Reference Citation Analysis]
268 Sun B, Huang S, Zhou J. Perspectives of Antidiabetic Drugs in Diabetes With Coronavirus Infections. Front Pharmacol 2020;11:592439. [PMID: 33584268 DOI: 10.3389/fphar.2020.592439] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
269 Leso V, Fontana L, Iavicoli I. Susceptibility to Coronavirus (COVID-19) in Occupational Settings: The Complex Interplay between Individual and Workplace Factors. Int J Environ Res Public Health 2021;18:1030. [PMID: 33503829 DOI: 10.3390/ijerph18031030] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
270 Martha JW, Wibowo A, Pranata R. Hypocalcemia is associated with severe COVID-19: A systematic review and meta-analysis. Diabetes Metab Syndr 2021;15:337-42. [PMID: 33493853 DOI: 10.1016/j.dsx.2021.01.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 13.0] [Reference Citation Analysis]
271 Bhattacharyya A, Seth A, Srivast N, Imeokparia M, Rai S. Coronavirus (COVID-19): A Systematic Review and Meta-analysis to Evaluate the Significance of Demographics and Comorbidities. Res Sq 2021:rs. [PMID: 33469575 DOI: 10.21203/rs.3.rs-144684/v1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
272 Zhang Y, Wang J, Tan N, Du K, Gao K, Zuo J, Lu X, Ma Y, Hou Y, Li Q, Xu H, Huang J, Huang Q, Na H, Wang J, Wang X, Xiao Y, Zhu J, Chen H, Liu Z, Wang M, Zhang L, Guo S, Wang W. Risk Factors in Patients with Diabetes Hospitalized for COVID-19: Findings from a Multicenter Retrospective Study. J Diabetes Res 2021;2021:3170190. [PMID: 33553435 DOI: 10.1155/2021/3170190] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
273 Shestakova MV, Kolbin AS, Galstyan GR, Arepeva MA, Zaitseva EL, Mayorov AY, Karpov OI, Proskurin MA, Kurylev AA, Dedov II. «DIARISK» — the first national prediabetes and diabetes mellitus type 2 risk calculator. Diabetes mellitus 2021;23:404-411. [DOI: 10.14341/dm12570] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
274 Kaufman-Shriqui V, Sherf-Dagan S, Boaz M, Birk R. Virtual nutrition consultation: what can we learn from the COVID-19 pandemic? Public Health Nutr 2021;24:1166-73. [PMID: 33436134 DOI: 10.1017/S1368980021000148] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
275 Grabowski D, Overgaard M, Meldgaard J, Johansen LB, Willaing I. Disrupted Self-Management and Adaption to New Diabetes Routines: A Qualitative Study of How People with Diabetes Managed Their Illness during the COVID-19 Lockdown. Diabetology 2021;2:1-15. [DOI: 10.3390/diabetology2010001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
276 Abdelmaksoud AA, Ghweil AA, Hassan MH, Rashad A, Khodeary A, Aref ZF, Sayed MAA, Elsamman MK, Bazeed SES. Olfactory Disturbances as Presenting Manifestation Among Egyptian Patients with COVID-19: Possible Role of Zinc. Biol Trace Elem Res 2021. [PMID: 33409924 DOI: 10.1007/s12011-020-02546-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 9.5] [Reference Citation Analysis]
277 Bricarello LP, Poltronieri F. Ethical and technical aspects of Nutrition teleconsultation in COVID-19 days. Rev Nutr 2021;34. [DOI: 10.1590/1678-9865202134200265] [Reference Citation Analysis]
278 Kaur M, Kaushal R. Synthesis, characterization and α ‐amylase and α ‐glucosidase inhibition studies of novel vanadyl chalcone complexes. Appl Organomet Chem 2021;35. [DOI: 10.1002/aoc.6042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
279 Shrivastava S, Shrivastava P. Insights into the relationship between COVID-19 and diabetes mellitus: Public health perspective. J Med Soc 2021;35:48. [DOI: 10.4103/jms.jms_2_21] [Reference Citation Analysis]
280 Shakyawar SK, Sethi S, Southekal S, Mishra NK, Guda C. Big Data Analytics for Modeling COVID-19 and Comorbidities: An Unmet Need. EAI/Springer Innovations in Communication and Computing 2021. [DOI: 10.1007/978-3-030-68936-0_10] [Reference Citation Analysis]
281 Urano E, Okamura T, Kamitani W, Kawaoka Y, Yasutomi Y. Comparison of young and elderly COVID-19 cynomolgus macaque models reflecting human COVID-19 pathological conditions. Translational and Regulatory Sciences 2021;4:20-24. [DOI: 10.33611/trs.2021-027] [Reference Citation Analysis]
282 Pramenković B, Prasko D, Pulo E, Rončević I, Ramić R, Rakovac A. Machine Learning Techniques for Predicting Outcomes of COVID-19 for Patients with preexisting Chronic Diseases. IFMBE Proceedings 2021. [DOI: 10.1007/978-3-030-73909-6_98] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
283 Sencio V, Machado MG, Trottein F. The lung-gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes. Mucosal Immunol 2021;14:296-304. [PMID: 33500564 DOI: 10.1038/s41385-020-00361-8] [Cited by in Crossref: 82] [Cited by in F6Publishing: 81] [Article Influence: 41.0] [Reference Citation Analysis]
284 Fathima AS, Mounika VL, Kumar VU, Gupta AK, Garapati P, Ravichandiran V, Dhingra S, Murti K. Mucormycosis: A triple burden in patients with diabetes during COVID-19 Pandemic. Health Sci Rev (Oxf) 2021;1:100005. [PMID: 34977914 DOI: 10.1016/j.hsr.2021.100005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
285 Nawata K. Estimation of Diabetes Prevalence, and Evaluation of Factors Affecting Blood Glucose Levels and Use of Medications in Japan. Health 2021;13:1431-1451. [DOI: 10.4236/health.2021.1312102] [Reference Citation Analysis]
286 Choudhuri J, Carter J, Nelson R, Skalina K, Osterbur-Badhey M, Johnston A, Goldstein D, Paroder M, Szymanski J. SARS-CoV-2 PCR cycle threshold at hospital admission associated with patient mortality. PLoS One. 2020;15:e0244777. [PMID: 33382805 DOI: 10.1371/journal.pone.0244777] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 9.3] [Reference Citation Analysis]
287 Medina-Enríquez MM, Lopez-León S, Carlos-Escalante JA, Aponte-Torres Z, Cuapio A, Wegman-Ostrosky T. ACE2: the molecular doorway to SARS-CoV-2. Cell Biosci 2020;10:148. [PMID: 33380340 DOI: 10.1186/s13578-020-00519-8] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 16.0] [Reference Citation Analysis]
288 Moin ASM, Al-Qaissi A, Sathyapalan T, Atkin SL, Butler AE. Mapping of type 2 diabetes proteins to COVID-19 biomarkers: A proteomic analysis. Metabol Open 2021;9:100074. [PMID: 33364597 DOI: 10.1016/j.metop.2020.100074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
289 Vitale RJ, Valtis YK, McDonell ME, Palermo NE, Fisher NDL. Euglycemic Diabetic Ketoacidosis with COVID-19 Infection in Patients with Type 2 Diabetes taking SGLT2 Inhibitors. Clin Case Rep. 2020;In press. [PMID: 33521255 DOI: 10.1016/j.aace.2020.11.019] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
290 Sundaram S, Soni M, Annigeri R. Urine abnormalities predict acute kidney injury in COVID-19 patients: An analysis of 110 cases in Chennai, South India. Diabetes Metab Syndr 2021;15:187-91. [PMID: 33383438 DOI: 10.1016/j.dsx.2020.12.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
291 Mithal A, Jevalikar G, Sharma R, Singh A, Farooqui KJ, Mahendru S, Krishnamurthy A, Dewan A, Budhiraja S. High prevalence of diabetes and other comorbidities in hospitalized patients with COVID-19 in Delhi, India, and their association with outcomes. Diabetes Metab Syndr 2021;15:169-75. [PMID: 33360081 DOI: 10.1016/j.dsx.2020.12.029] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 8.3] [Reference Citation Analysis]
292 Azevedo RB, Botelho BG, Hollanda JVGD, Ferreira LVL, Andrade LZJD, Oei SSML, Mello TDS, Muxfeldt ES. Practical Approach to Acute Coronary Syndrome in Patients with COVID-19. International Journal of Cardiovascular Sciences 2020. [DOI: 10.36660/ijcs.20200150] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
293 Bala R, Srivastava A, Potsangbam T, Anal L, Ningthoujam GD. Self care practices and psychological distress among diabetic patients in Manipur during COVID-19: A scenario from the North East. Diabetes Metab Syndr 2021;15:93-8. [PMID: 33316765 DOI: 10.1016/j.dsx.2020.12.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
294 Singh AK, Singh R, Saboo B, Misra A. Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: A Critical Appraisal of Literature. Diabetes Metab Syndr 2021;15:159-67. [PMID: 33352455 DOI: 10.1016/j.dsx.2020.12.026] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
295 Orioli L, Servais T, Belkhir L, Laterre PF, Thissen JP, Vandeleene B, Maiter D, Yombi JC, Hermans MP. Clinical characteristics and short-term prognosis of in-patients with diabetes and COVID-19: A retrospective study from an academic center in Belgium. Diabetes Metab Syndr 2021;15:149-57. [PMID: 33352454 DOI: 10.1016/j.dsx.2020.12.020] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
296 Oliveira TL, Melo IS, Cardoso-Sousa L, Santos IA, El Zoghbi MB, Shimoura CG, Georjutti RP, Castro OW, Goulart LR, Jardim ACG, Cunha TM, Sabino-Silva R. Pathophysiology of SARS-CoV-2 in Lung of Diabetic Patients. Front Physiol 2020;11:587013. [PMID: 33362575 DOI: 10.3389/fphys.2020.587013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
297 Quinn LM, Davies MJ, Northern A, Brough C, Schreder S, Stribling B, Khunti K, Hadjiconstantinou M. Use of MyDesmond digital education programme to support self-management in people with type 2 diabetes during the COVID-19 pandemic. Diabet Med 2021;38:e14469. [PMID: 33274489 DOI: 10.1111/dme.14469] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
298 Bellido V, Pérez A. Inpatient Hyperglycemia Management and COVID-19. Diabetes Ther 2021;12:121-32. [PMID: 33278017 DOI: 10.1007/s13300-020-00966-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
299 Katz J, Yue S, Xue W. Increased risk for COVID-19 in patients with vitamin D deficiency. Nutrition 2021;84:111106. [PMID: 33418230 DOI: 10.1016/j.nut.2020.111106] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 15.7] [Reference Citation Analysis]
300 Dukhinova M, Kokinos E, Kuchur P, Komissarov A, Shtro A. Macrophage-derived cytokines in pneumonia: Linking cellular immunology and genetics. Cytokine Growth Factor Rev 2021;59:46-61. [PMID: 33342718 DOI: 10.1016/j.cytogfr.2020.11.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
301 Li B, Iqbal SZ, Avellaneda Ojeda AA, Stevens J, Saunders J, Naqvi MF, Shah AA. Vulnerable Populations During the COVID-19 Pandemic. Psychiatric Annals 2020;50:531-5. [DOI: 10.3928/00485713-20201028-01] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
302 Seiglie J, Platt J, Cromer SJ, Bunda B, Foulkes AS, Bassett IV, Hsu J, Meigs JB, Leong A, Putman MS, Triant VA, Wexler DJ, Manne-Goehler J. Diabetes as a Risk Factor for Poor Early Outcomes in Patients Hospitalized With COVID-19. Diabetes Care 2020;43:2938-44. [PMID: 32847827 DOI: 10.2337/dc20-1506] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 21.7] [Reference Citation Analysis]
303 Abu-Farha M, Al-Mulla F, Thanaraj TA, Kavalakatt S, Ali H, Abdul Ghani M, Abubaker J. Impact of Diabetes in Patients Diagnosed With COVID-19. Front Immunol 2020;11:576818. [PMID: 33335527 DOI: 10.3389/fimmu.2020.576818] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 12.0] [Reference Citation Analysis]
304 Patrício A, Costa RS, Henriques R. Predictability of COVID-19 Hospitalizations, Intensive Care Unit Admissions, and Respiratory Assistance in Portugal: Longitudinal Cohort Study (Preprint).. [DOI: 10.2196/preprints.26075] [Reference Citation Analysis]
305 Safdarian AR, Momenzadeh K, Kahe F, Farhangnia P, Rezaei N. Death due to COVID-19 in a patient with diabetes, epilepsy, and gout comorbidities. Clin Case Rep 2020. [PMID: 33362925 DOI: 10.1002/ccr3.3557] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
306 Kolin DA, Kulm S, Christos PJ, Elemento O. Clinical, regional, and genetic characteristics of Covid-19 patients from UK Biobank. PLoS One 2020;15:e0241264. [PMID: 33201886 DOI: 10.1371/journal.pone.0241264] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
307 Lew S, Manes P, Smith B. Coinfection with SARS-CoV-2 and Influenza A Virus in a 32-Year-Old Man. Am J Case Rep 2020;21:e926092. [PMID: 33188162 DOI: 10.12659/AJCR.926092] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
308 Kipps S, Paul A, Vasireddy S. Incidence of COVID-19 in patients with rheumatic disease: is prior health education more important than shielding advice during the pandemic? Clin Rheumatol 2021;40:1575-9. [PMID: 33174109 DOI: 10.1007/s10067-020-05494-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
309 Quagliariello V, Bonelli A, Caronna A, Conforti G, Iovine M, Carbone A, Berretta M, Botti G, Maurea N. SARS-CoV-2 Infection and Cardioncology: From Cardiometabolic Risk Factors to Outcomes in Cancer Patients. Cancers (Basel) 2020;12:E3316. [PMID: 33182653 DOI: 10.3390/cancers12113316] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
310 Ding X, Zhang J, Liu L, Yuan X, Zang X, Lu F, He P, Wang Q, Zhang X, Xu Y, Li X, Liu Y, Li Q, Tan X, Zheng Y, Lin X, Liu Y. High-density lipoprotein cholesterol as a factor affecting virus clearance in covid-19 patients. Respir Med 2020;175:106218. [PMID: 33181413 DOI: 10.1016/j.rmed.2020.106218] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
311 Müller-Wieland D, Marx N, Dreher M, Fritzen K, Schnell O. COVID-19 and Cardiovascular Comorbidities. Exp Clin Endocrinol Diabetes 2020. [PMID: 33157558 DOI: 10.1055/a-1269-1405] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
312 Emmanuel N, Zibara V, Saad JM, Iskandar R, Abi Assaad R, Ammanouil E, Bilen Y, Chidiac G, El Ahmar N. COVID-19: What We Know So Far. Int J Clin Res 2020;1:73-108. [DOI: 10.38179/ijcr.v1i1.19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
313 Alpert N, Rapp JL, Marcellino B, Lieberman-Cribbin W, Flores R, Taioli E. Clinical Course of Cancer Patients With COVID-19: A Retrospective Cohort Study. JNCI Cancer Spectr 2021;5:pkaa085. [PMID: 33437923 DOI: 10.1093/jncics/pkaa085] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
314 Gallwitz B. COVID-19 und Diabetes: Gefährliche Interaktionen. Deutsches Ärzteblatt Online 2020. [DOI: 10.3238/persdia.2020.10.30.01] [Reference Citation Analysis]
315 Biscetti F, Rando MM, Nardella E, Cecchini AL, Bruno P, Landolfi R, Flex A. Cardiovascular Disease and SARS-CoV-2: the Role of Host Immune Response Versus Direct Viral Injury. Int J Mol Sci 2020;21:E8141. [PMID: 33143371 DOI: 10.3390/ijms21218141] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
316 Alsadhan I, Alruwashid S, Alhamad M, Alajmi S, Alshehri S, Alfadhli E, Ekhzaimy A. Diabetic ketoacidosis precipitated by Coronavirus disease 2019 infection: Case series. Curr Ther Res Clin Exp 2020;93:100609. [PMID: 33132404 DOI: 10.1016/j.curtheres.2020.100609] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
317 Sturza A, Marian CV, Muntean DM, Crețu OM. Angiotensin-Converting-Enzyme 2 and SARS-CoV2: A Dangerous Liaison. Timisoara Med 2020;2020:1. [DOI: 10.35995/tmj20200108] [Reference Citation Analysis]
318 Huda MSB, Shaho S, Trivedi B, Fraterrigo G, Chandrarajan L, Zolfaghari P, Dovey TM, Garrett CG, Chowdhury TA. Diabetic emergencies during the COVID-19 pandemic: A case-control study. Diabet Med. 2021;38:e14416. [PMID: 33025636 DOI: 10.1111/dme.14416] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
319 Sadhu AR, Serrano IA, Xu J, Nisar T, Lucier J, Pandya AR, Patham B. Continuous Glucose Monitoring in Critically Ill Patients With COVID-19: Results of an Emergent Pilot Study. J Diabetes Sci Technol 2020;14:1065-73. [PMID: 33063556 DOI: 10.1177/1932296820964264] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 10.3] [Reference Citation Analysis]
320 Kalocsay M, Maliga Z, Nirmal AJ, Eisert RJ, Bradshaw GA, Solomon IH, Chen Y, Pelletier RJ, Jacobson CA, Mintseris J, Padera RF, Martinot AJ, Barouch DH, Santagata S, Sorger PK. Multiplexed proteomics and imaging of resolving and lethal SARS-CoV-2 infection in the lung.. [DOI: 10.1101/2020.10.14.339952] [Reference Citation Analysis]
321 Shivane VK, Lila AR, Bandgar TR. Type 2 diabetic Asian Indians and COVID-19: Lessons learnt so far from the ongoing pandemic. J Postgrad Med 2020;66:179-81. [PMID: 33037170 DOI: 10.4103/jpgm.JPGM_602_20] [Reference Citation Analysis]
322 N M, S W. Safety of Metformin in Hospitalized Patients with COVID-19. Diab Res Open Access 2020;2:68-71. [DOI: 10.36502/2020/droa.6171] [Reference Citation Analysis]
323 Guarnotta V, Ferrigno R, Martino M, Barbot M, Isidori AM, Scaroni C, Ferrante A, Arnaldi G, Pivonello R, Giordano C. Glucocorticoid excess and COVID-19 disease. Rev Endocr Metab Disord 2020. [PMID: 33025384 DOI: 10.1007/s11154-020-09598-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
324 Doupis J, Avramidis K. Managing Diabetes During the COVID-19 Pandemic. Eur Endocrinol 2020;16:85-7. [PMID: 33117436 DOI: 10.17925/EE.2020.16.2.85] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
325 Siddiqui RS, Zirkiyeva M, Saliaj M. Onset of Ketosis-Prone Diabetes in the Setting of COVID-19 Infection. Cureus 2020;12:e10779. [PMID: 33154847 DOI: 10.7759/cureus.10779] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
326 Bepouka BI, Mandina M, Makulo JR, Longokolo M, Odio O, Mayasi N, Pata T, Nsangana G, Tshikangu F, Mangala D, Maheshe D, Nkarnkwin S, Muamba J, Ndaie G, Ngwizani R, Yanga Y, Nkodila A, Keke H, Kokusa Y, Lepira F, Kashongwe I, Mbula M, Kayembe JM, Situakibanza H. Predictors of mortality in COVID-19 patients at Kinshasa University Hospital, Democratic Republic of the Congo, from March to June 2020. Pan Afr Med J 2020;37:105. [PMID: 33425138 DOI: 10.11604/pamj.2020.37.105.25279] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
327 Seetharaman V, N R, R BM, Ashok NG. KNOWLEDGE OF HIV/AIDS AND COVID-19 PANDEMIC AMONG DENTAL UNDERGRADUATE STUDENTS. ijsr 2020. [DOI: 10.36106/ijsr/6509256] [Reference Citation Analysis]
328 Lundholm MD, Poku C, Emanuele N, Emanuele MA, Lopez N. SARS-CoV-2 (COVID-19) and the Endocrine System. J Endocr Soc 2020;4:bvaa144. [PMID: 33145472 DOI: 10.1210/jendso/bvaa144] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 9.3] [Reference Citation Analysis]
329 Silverii GA, Monami M, Cernigliaro A, Vigneri E, Guarnotta V, Scondotto S, Allotta VA, Conti M, Giordano C, Mannucci E. Are diabetes and its medications risk factors for the development of COVID-19? Data from a population-based study in Sicily. Nutr Metab Cardiovasc Dis 2021;31:396-8. [PMID: 33223405 DOI: 10.1016/j.numecd.2020.09.028] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
330 Grabia M, Markiewicz-Żukowska R, Puścion-Jakubik A, Bielecka J, Nowakowski P, Gromkowska-Kępka K, Mielcarek K, Socha K. The Nutritional and Health Effects of the COVID-19 Pandemic on Patients with Diabetes Mellitus. Nutrients 2020;12:E3013. [PMID: 33008059 DOI: 10.3390/nu12103013] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 11.0] [Reference Citation Analysis]
331 Tsatsakis A, Calina D, Falzone L, Petrakis D, Mitrut R, Siokas V, Pennisi M, Lanza G, Libra M, Doukas SG, Doukas PG, Kavali L, Bukhari A, Gadiparthi C, Vageli DP, Kofteridis DP, Spandidos DA, Paoliello MMB, Aschner M, Docea AO. SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19. Food Chem Toxicol 2020;146:111769. [PMID: 32979398 DOI: 10.1016/j.fct.2020.111769] [Cited by in Crossref: 90] [Cited by in F6Publishing: 98] [Article Influence: 30.0] [Reference Citation Analysis]
332 Tsatsakis A, Calina D, Falzone L, Petrakis D, Mitrut R, Siokas V, Pennisi M, Lanza G, Libra M, Doukas SG, Doukas PG, Kavali L, Bukhari A, Gadiparthi C, Vageli DP, Kofteridis DP, Spandidos DA, Paoliello MMB, Aschner M, Docea AO. SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19. Food Chem Toxicol 2020;146:111769. [PMID: 32979398 DOI: 10.1016/j.fct.2020.111769] [Reference Citation Analysis]
333 Choudhuri J, Carter J, Nelson R, Skalina K, Osterbur-badhey M, Johnson A, Goldstein D, Paroder M, Szymanski J. SARS-CoV-2 PCR cycle threshold at hospital admission associated with Patient Mortality.. [DOI: 10.1101/2020.09.16.20195941] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
334 The COCORICO Collaborative Group, Tran V, Mahévas M, Bani-sadr F, Robineau O, Perpoint T, Perrodeau E, Gallay L, Ravaud P, Goehringer F, Lescure F. Association between corticosteroids and intubation or death among patients with COVID-19 pneumonia in non-ICU settings: an observational study using of real-world data from 51 hospitals in France and Luxembourg.. [DOI: 10.1101/2020.09.16.20195750] [Reference Citation Analysis]
335 Bolouri H, Speake C, Skibinski D, Long SA, Hocking AM, Campbell DJ, Hamerman JA, Malhotra U, Buckner JH, the BRI COVID-19 Research Team. The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity.. [DOI: 10.1101/2020.09.18.303420] [Reference Citation Analysis]
336 Pathak SK, Pandey S, Pandey A, Salunke AA, Thivari P, Ratna HVK, Chawla J. Focus on uncommon symptoms of COVID-19: Potential reason for spread of infection. Diabetes Metab Syndr 2020;14:1873-4. [PMID: 32998094 DOI: 10.1016/j.dsx.2020.09.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
337 Gupta R, Misra A. Clinical considerations in patients with diabetes during times of COVID19: An update on lifestyle factors and antihyperglycemic drugs with focus on India. Diabetes Metab Syndr 2020;14:1777-81. [PMID: 32942253 DOI: 10.1016/j.dsx.2020.09.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
338 Elamari S, Motaib I, Zbiri S, Elaidaoui K, Chadli A, Elkettani C. Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2. Pan Afr Med J 2020;37:32. [PMID: 33209159 DOI: 10.11604/pamj.2020.37.32.25192] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
339 Minissian MB, Ballard-Hernandez J, Coleman B, Chavez J, Sheffield L, Joung S, Parker A, Stepien SJ, Romero J, Floríndez LI, Simons CD, De Jesus M, Marshall D. Multispecialty Nursing During COVID-19:: Lessons Learned in Southern California. Nurse Lead 2021;19:170-8. [PMID: 32922217 DOI: 10.1016/j.mnl.2020.08.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
340 Soliman AT, Prabhakaran Nair A, Al Masalamani MS, De Sanctis V, Abu Khattab MA, Alsaud AE, Sasi S, Ali EA, Ola A H, Iqbal FM, Nashwan AJ, Fahad J, El Madhoun I, Yassin MA. Prevalence, clinical manifestations, and biochemical data of type 2 diabetes mellitus versus nondiabetic symptomatic patients with COVID-19: A comparative study. Acta Biomed 2020;91:e2020010. [PMID: 32921708 DOI: 10.23750/abm.v91i3.10214] [Cited by in F6Publishing: 27] [Reference Citation Analysis]
341 Stein RA, Young LM. From ACE2 to COVID-19: A multiorgan endothelial disease. Int J Infect Dis 2020;100:425-30. [PMID: 32896660 DOI: 10.1016/j.ijid.2020.08.083] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
342 Buetti N, Trimboli P, Mazzuchelli T, Lo Priore E, Balmelli C, Trkola A, Conti M, Martinetti G, Elzi L, Ceschi A, Consonni V, Ogna A, Forni-Ogna V, Bernasconi E. Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients. Endocrine 2020;70:454-60. [PMID: 32870469 DOI: 10.1007/s12020-020-02465-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
343 Grabowski D, Meldgaard J, Hulvej Rod M. Altered Self-Observations, Unclear Risk Perceptions and Changes in Relational Everyday Life: A Qualitative Study of Psychosocial Life with Diabetes during the COVID-19 Lockdown. Societies 2020;10:63. [DOI: 10.3390/soc10030063] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
344 Smith M, Honce R, Schultz-Cherry S. Metabolic Syndrome and Viral Pathogenesis: Lessons from Influenza and Coronaviruses. J Virol. 2020;94. [PMID: 32661141 DOI: 10.1128/jvi.00665-20] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
345 Bertocchi I, Foglietta F, Collotta D, Eva C, Brancaleone V, Thiemermann C, Collino M. The hidden role of NLRP3 inflammasome in obesity-related COVID-19 exacerbations: Lessons for drug repurposing. Br J Pharmacol 2020;177:4921-30. [PMID: 32776354 DOI: 10.1111/bph.15229] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
346 Liu Z, Bai X, Han X, Jiang W, Qiu L, Chen S, Yu X. The association of diabetes and the prognosis of COVID-19 patients: A retrospective study. Diabetes Res Clin Pract 2020;169:108386. [PMID: 32853685 DOI: 10.1016/j.diabres.2020.108386] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 6.3] [Reference Citation Analysis]
347 Zhu B, Jin S, Wu L, Hu C, Wang Z, Bu L, Sun H, Wang X, Qu S, Chen D. J-shaped association between fasting blood glucose levels and COVID-19 severity in patients without diabetes. Diabetes Res Clin Pract 2020;168:108381. [PMID: 32853687 DOI: 10.1016/j.diabres.2020.108381] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
348 Zhang M, Gao W. COVID-19 and diabetes cutaneous comorbidity. Metabol Open 2020;7:100055. [PMID: 32864603 DOI: 10.1016/j.metop.2020.100055] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
349 Horrell LN, Hayes S, Herbert LB, Macturk K, Lawhon L, Valle CG, Bhowmick A. Telemedicine Use and Health-Related Concerns of Patients With Chronic Conditions During COVID-19: Survey of Members of Online Health Communities (Preprint).. [DOI: 10.2196/preprints.23795] [Reference Citation Analysis]
350 Napoli R. Diabetes and Covid-19: An interplay difficult to dissect. Diabetes Metab Res Rev 2021;37:e3387. [PMID: 32818297 DOI: 10.1002/dmrr.3387] [Reference Citation Analysis]
351 Hariyanto TI, Kurniawan A. Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection. Obes Med 2020;19:100290. [PMID: 32844132 DOI: 10.1016/j.obmed.2020.100290] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 22.7] [Reference Citation Analysis]
352 Pal R, Banerjee M, Yadav U, Bhattacharjee S. Clinical profile and outcomes in COVID-19 patients with diabetic ketoacidosis: A systematic review of literature. Diabetes Metab Syndr. 2020;14:1563-1569. [PMID: 32853901 DOI: 10.1016/j.dsx.2020.08.015] [Cited by in Crossref: 60] [Cited by in F6Publishing: 49] [Article Influence: 20.0] [Reference Citation Analysis]
353 Henry Akintobi T, Jacobs T, Sabbs D, Holden K, Braithwaite R, Johnson LN, Dawes D, Hoffman L. Community Engagement of African Americans in the Era of COVID-19: Considerations, Challenges, Implications, and Recommendations for Public Health. Prev Chronic Dis 2020;17:E83. [PMID: 32790605 DOI: 10.5888/pcd17.200255] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
354 Lisco G, De Tullio A, Giagulli VA, Guastamacchia E, De Pergola G, Triggiani V. Hypothesized mechanisms explaining poor prognosis in type 2 diabetes patients with COVID-19: a review. Endocrine 2020;70:441-53. [PMID: 32779091 DOI: 10.1007/s12020-020-02444-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
355 Diabetes India, National Diabetes Obesity and Cholesterol Foundation (NDOC), and Diabetes Expert Group, India. Strict glycemic control is needed in times of COVID19 epidemic in India: A Call for action for all physicians. Diabetes Metab Syndr 2020;14:1579-81. [PMID: 32947758 DOI: 10.1016/j.dsx.2020.08.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
356 Balmeh N, Mahmoudi S, Mohammadi N, Karabedianhajiabadi A. Predicted therapeutic targets for COVID-19 disease by inhibiting SARS-CoV-2 and its related receptors. Inform Med Unlocked 2020;20:100407. [PMID: 32835083 DOI: 10.1016/j.imu.2020.100407] [Cited by in Crossref: 35] [Cited by in F6Publishing: 43] [Article Influence: 11.7] [Reference Citation Analysis]
357 Taneera J, El-Huneidi W, Hamad M, Mohammed AK, Elaraby E, Hachim MY. Expression Profile of SARS-CoV-2 Host Receptors in Human Pancreatic Islets Revealed Upregulation of ACE2 in Diabetic Donors. Biology (Basel). 2020;9. [PMID: 32784802 DOI: 10.3390/biology9080215] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 9.0] [Reference Citation Analysis]
358 Mishra PK, Tandon R, Byrareddy SN. Diabetes and COVID-19 risk: an miRNA perspective. Am J Physiol Heart Circ Physiol 2020;319:H604-9. [PMID: 32762561 DOI: 10.1152/ajpheart.00489.2020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
359 Weenink RP, Preckel B, Hulst AH, Hermanides J, de Jong MD, Schlack WS, Stevens MF, Sperna Weiland NH, Hollmann MW. Second Update for Anaesthetists on Clinical Features of COVID-19 Patients and Relevant Management. J Clin Med 2020;9:E2542. [PMID: 32781614 DOI: 10.3390/jcm9082542] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
360 Ahmed WN, Arun CS, Koshy TG, Nair A, Sankar P, Rasheed SA, Ann R. Management of diabetes during fasting and COVID-19 - Challenges and solutions. J Family Med Prim Care 2020;9:3797-806. [PMID: 33110770 DOI: 10.4103/jfmpc.jfmpc_845_20] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
361 Das S, K R A, Birangal SR, Nikam AN, Pandey A, Mutalik S, Joseph A. Role of comorbidities like diabetes on severe acute respiratory syndrome coronavirus-2: A review. Life Sci 2020;258:118202. [PMID: 32758625 DOI: 10.1016/j.lfs.2020.118202] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
362 Gujral UP, Johnson L, Nielsen J, Vellanki P, Haw JS, Davis GM, Weber MB, Pasquel FJ. Preparedness cycle to address transitions in diabetes care during the COVID-19 pandemic and future outbreaks. BMJ Open Diabetes Res Care 2020;8:e001520. [PMID: 32690631 DOI: 10.1136/bmjdrc-2020-001520] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
363 de la Rica R, Borges M, Aranda M, Del Castillo A, Socias A, Payeras A, Rialp G, Socias L, Masmiquel L, Gonzalez-Freire M. Low Albumin Levels Are Associated with Poorer Outcomes in a Case Series of COVID-19 Patients in Spain: A Retrospective Cohort Study. Microorganisms. 2020;8. [PMID: 32722020 DOI: 10.3390/microorganisms8081106] [Cited by in Crossref: 42] [Cited by in F6Publishing: 49] [Article Influence: 14.0] [Reference Citation Analysis]
364 Daryabor G, Atashzar MR, Kabelitz D, Meri S, Kalantar K. The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System. Front Immunol 2020;11:1582. [PMID: 32793223 DOI: 10.3389/fimmu.2020.01582] [Cited by in Crossref: 89] [Cited by in F6Publishing: 99] [Article Influence: 29.7] [Reference Citation Analysis]
365 Palermo NE, Sadhu AR, McDonnell ME. Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations. J Clin Endocrinol Metab 2020;105:dgaa360. [PMID: 32556147 DOI: 10.1210/clinem/dgaa360] [Cited by in Crossref: 70] [Cited by in F6Publishing: 74] [Article Influence: 23.3] [Reference Citation Analysis]
366 Pal R, Yadav U, Grover S, Saboo B, Verma A, Bhadada SK. Knowledge, attitudes and practices towards COVID-19 among young adults with Type 1 Diabetes Mellitus amid the nationwide lockdown in India: A cross-sectional survey. Diabetes Res Clin Pract 2020;166:108344. [PMID: 32710997 DOI: 10.1016/j.diabres.2020.108344] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 10.7] [Reference Citation Analysis]
367 Attri B, Goyal A, Gupta Y, Tandon N. Basal-Bolus Insulin Regimen for Hospitalised Patients with COVID-19 and Diabetes Mellitus: A Practical Approach. Diabetes Ther 2020;11:2177-94. [PMID: 32683660 DOI: 10.1007/s13300-020-00873-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
368 Kempuraj D, Selvakumar GP, Ahmed ME, Raikwar SP, Thangavel R, Khan A, Zaheer SA, Iyer SS, Burton C, James D, Zaheer A. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation. Neuroscientist 2020;26:402-14. [PMID: 32684080 DOI: 10.1177/1073858420941476] [Cited by in Crossref: 122] [Cited by in F6Publishing: 132] [Article Influence: 40.7] [Reference Citation Analysis]
369 Ghweil AA, Hassan MH, Khodeary A, Mohamed AO, Mohammed HM, Abdelazez AA, Osman HA, Bazeed SES. Characteristics, Outcomes and Indicators of Severity for COVID-19 Among Sample of ESNA Quarantine Hospital's Patients, Egypt: A Retrospective Study. Infect Drug Resist 2020;13:2375-83. [PMID: 32765012 DOI: 10.2147/IDR.S263489] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 12.3] [Reference Citation Analysis]
370 Wijaya I, Andhika R, Huang I. Hypercoagulable state in COVID-19 with diabetes mellitus and obesity: Is therapeutic-dose or higher-dose anticoagulant thromboprophylaxis necessary? Diabetes Metab Syndr 2020;14:1241-2. [PMID: 32683322 DOI: 10.1016/j.dsx.2020.07.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
371 Bello-Chavolla OY, Bahena-López JP, Antonio-Villa NE, Vargas-Vázquez A, González-Díaz A, Márquez-Salinas A, Fermín-Martínez CA, Naveja JJ, Aguilar-Salinas CA. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico. J Clin Endocrinol Metab 2020;105:dgaa346. [PMID: 32474598 DOI: 10.1210/clinem/dgaa346] [Cited by in Crossref: 221] [Cited by in F6Publishing: 243] [Article Influence: 73.7] [Reference Citation Analysis]
372 Caballero AE, Ceriello A, Misra A, Aschner P, McDonnell ME, Hassanein M, Ji L, Mbanya JC, Fonseca VA. COVID-19 in people living with diabetes: An international consensus. J Diabetes Complications 2020;34:107671. [PMID: 32651031 DOI: 10.1016/j.jdiacomp.2020.107671] [Cited by in Crossref: 73] [Cited by in F6Publishing: 77] [Article Influence: 24.3] [Reference Citation Analysis]
373 Wicaksana AL, Hertanti NS, Ferdiana A, Pramono RB. Diabetes management and specific considerations for patients with diabetes during coronavirus diseases pandemic: A scoping review. Diabetes Metab Syndr 2020;14:1109-20. [PMID: 32659694 DOI: 10.1016/j.dsx.2020.06.070] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 11.0] [Reference Citation Analysis]
374 Alromaihi D, Alamuddin N, George S. Sustainable diabetes care services during COVID-19 pandemic. Diabetes Res Clin Pract 2020;166:108298. [PMID: 32623031 DOI: 10.1016/j.diabres.2020.108298] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 10.7] [Reference Citation Analysis]
375 Trottein F, Sokol H. Potential Causes and Consequences of Gastrointestinal Disorders during a SARS-CoV-2 Infection. Cell Rep 2020;32:107915. [PMID: 32649864 DOI: 10.1016/j.celrep.2020.107915] [Cited by in Crossref: 87] [Cited by in F6Publishing: 86] [Article Influence: 29.0] [Reference Citation Analysis]
376 Schoser B, Baum P, Boentert M, Dillmann K, Emmer A, Knauss S, Enax-krumova E, Grosskreutz J, Güttsches A, Hellwig K, Holzapfel K, Kornblum C, Lehmann H, Melms A, Meyer T, Petri S, Pilgram L, Reiners K, Saak A, Schäfer J, Schmidt J, Schneider-gold C, Schons M, Urban PP, Vorgerd M, Young P, Zierz S. SARS-CoV-2/COVID-19 und neuromuskuläre Erkrankungen. DGNeurologie 2020;3:310-320. [DOI: 10.1007/s42451-020-00198-2] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
377 Cefalu WT, James SP, Star RA. Opportunities for Research for COVID-19 in the Mission of NIDDK. Diabetes Care 2020;43:1435-7. [PMID: 32409497 DOI: 10.2337/dci20-0025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
378 Pranata R, Permana H, Huang I, Lim MA, Soetedjo NNM, Supriyadi R, Soeroto AY, Alkatiri AA, Firman D, Lukito AA. The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Diabetes Metab Syndr 2020;14:983-90. [PMID: 32615377 DOI: 10.1016/j.dsx.2020.06.047] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 21.7] [Reference Citation Analysis]
379 Shestakova MV, Mokrysheva NG, Dedov II. Course and treatment of diabetes mellitus in the context of COVID-19. Diabetes mellitus 2020;23:132-9. [DOI: 10.14341/dm12418] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
380 Lim MA, Huang I, Yonas E, Vania R, Pranata R. A wave of non-communicable diseases following the COVID-19 pandemic. Diabetes Metab Syndr 2020;14:979-80. [PMID: 32610263 DOI: 10.1016/j.dsx.2020.06.050] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 11.7] [Reference Citation Analysis]
381 Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P, Hosein Z, Padda I, Mangat J, Altaf M. Comorbidity and its Impact on Patients with COVID-19. SN Compr Clin Med.  2020: 1-8. [PMID: 32838147 DOI: 10.1007/s42399-020-00363-4] [Cited by in Crossref: 513] [Cited by in F6Publishing: 378] [Article Influence: 171.0] [Reference Citation Analysis]
382 Rychter AM, Zawada A, Ratajczak AE, Dobrowolska A, Krela-Kaźmierczak I. Should patients with obesity be more afraid of COVID-19? Obes Rev 2020;21:e13083. [PMID: 32583537 DOI: 10.1111/obr.13083] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 13.0] [Reference Citation Analysis]
383 Permana H, Soetedjo NNM. Is subcutaneous insulin administration adequate for the management of hyperglycemic crisis in COVID-19? Diabetes Metab Syndr 2020;14:947-8. [PMID: 32599534 DOI: 10.1016/j.dsx.2020.06.032] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
384 Chatterjee S, Ghosh R, Biswas P, Dubey S, Guria RT, Sharma CB, Kalra S. COVID-19: the endocrine opportunity in a pandemic. Minerva Endocrinol 2020;45:204-27. [PMID: 32548995 DOI: 10.23736/S0391-1977.20.03216-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
385 Lim MA, Pranata R. The insidious threat of jamu and unregulated traditional medicines in the COVID-19 era. Diabetes Metab Syndr 2020;14:895-6. [PMID: 32563942 DOI: 10.1016/j.dsx.2020.06.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
386 Singh AK, Khunti K. Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A narrative review. Diabetes Res Clin Pract 2020;165:108266. [PMID: 32533989 DOI: 10.1016/j.diabres.2020.108266] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 16.0] [Reference Citation Analysis]
387 Costa FF, Rosário WR, Ribeiro Farias AC, de Souza RG, Duarte Gondim RS, Barroso WA. Metabolic syndrome and COVID-19: An update on the associated comorbidities and proposed therapies. Diabetes Metab Syndr 2020;14:809-14. [PMID: 32540733 DOI: 10.1016/j.dsx.2020.06.016] [Cited by in Crossref: 72] [Cited by in F6Publishing: 76] [Article Influence: 24.0] [Reference Citation Analysis]
388 Singh AK, Singh R. Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19? Diabetes Res Clin Pract 2020;165:108268. [PMID: 32533990 DOI: 10.1016/j.diabres.2020.108268] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
389 Schofield J, Leelarathna L, Thabit H. COVID-19: Impact of and on Diabetes. Diabetes Ther 2020;11:1429-35. [PMID: 32506222 DOI: 10.1007/s13300-020-00847-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
390 Madhu SV. Post COVID-19 diabetes care-lessons and challenges. Int J Diabetes Dev Ctries 2020;:1-3. [PMID: 32837089 DOI: 10.1007/s13410-020-00831-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
391 Nakajima K. Serious Conditions in COVID-19 Accompanied With a Feature of Metabolic Syndrome. J Clin Med Res 2020;12:273-5. [PMID: 32489501 DOI: 10.14740/jocmr4187] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
392 Pal R, Bhadada SK. Managing common endocrine disorders amid COVID-19 pandemic. Diabetes Metab Syndr 2020;14:767-71. [PMID: 32521463 DOI: 10.1016/j.dsx.2020.05.050] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
393 Bellido V, Pérez A. Consequences of COVID-19 on people with diabetes. Endocrinología, Diabetes y Nutrición (English ed ) 2020;67:355-356. [DOI: 10.1016/j.endien.2020.04.008] [Reference Citation Analysis]
394 Cuschieri S, Grech S. COVID-19 and diabetes: The why, the what and the how. J Diabetes Complications 2020;34:107637. [PMID: 32456846 DOI: 10.1016/j.jdiacomp.2020.107637] [Cited by in Crossref: 66] [Cited by in F6Publishing: 68] [Article Influence: 22.0] [Reference Citation Analysis]
395 Scheen AJ, Marre M, Thivolet C. Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports. Diabetes Metab 2020;46:265-71. [PMID: 32447101 DOI: 10.1016/j.diabet.2020.05.008] [Cited by in Crossref: 82] [Cited by in F6Publishing: 86] [Article Influence: 27.3] [Reference Citation Analysis]
396 Kabashneh S, Ali H, Alkassis S. Multi-Organ Failure in a Patient With Diabetes due to COVID-19 With Clear Lungs. Cureus 2020;12:e8147. [PMID: 32550066 DOI: 10.7759/cureus.8147] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
397 Tao F, Tang X, Tao H, Luo Y, Cao H, Xiang W, Zhao Y, Jin L. Surgical treatment of diabetic foot ulcers during the COVID-19 pandemic in China. J Diabetes Complications 2020;34:107622. [PMID: 32419767 DOI: 10.1016/j.jdiacomp.2020.107622] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
398 Sun DW, Zhang D, Tian RH, Li Y, Wang YS, Cao J, Tang Y, Zhang N, Zan T, Gao L, Huang YZ, Cui CL, Wang DX, Zheng Y, Lv GY. The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: A sentinel? Clin Chim Acta 2020;508:122-9. [PMID: 32417210 DOI: 10.1016/j.cca.2020.05.027] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 17.0] [Reference Citation Analysis]
399 Orioli L, Hermans MP, Thissen JP, Maiter D, Vandeleene B, Yombi JC. COVID-19 in diabetic patients: Related risks and specifics of management. Ann Endocrinol (Paris) 2020;81:101-9. [PMID: 32413342 DOI: 10.1016/j.ando.2020.05.001] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 15.3] [Reference Citation Analysis]
400 Bellido V, Pérez A. Consequences of COVID-19 on people with diabetes. Endocrinol Diabetes Nutr (Engl Ed) 2020;67:355-6. [PMID: 32475769 DOI: 10.1016/j.endinu.2020.04.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
401 Kumar A, Arora A, Sharma P, Anikhindi SA, Bansal N, Singla V, Khare S, Srivastava A. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes Metab Syndr. 2020;14:535-545. [PMID: 32408118 DOI: 10.1016/j.dsx.2020.04.044] [Cited by in Crossref: 325] [Cited by in F6Publishing: 349] [Article Influence: 108.3] [Reference Citation Analysis]
402 Pal R, Bhadada SK. COVID-19 and diabetes mellitus: An unholy interaction of two pandemics. Diabetes Metab Syndr. 2020;14:513-517. [PMID: 32388331 DOI: 10.1016/j.dsx.2020.04.049] [Cited by in Crossref: 135] [Cited by in F6Publishing: 96] [Article Influence: 45.0] [Reference Citation Analysis]
403 Means C. Letter to the Editor: Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy. Metabolism. 2020;108:154254. [PMID: 32360397 DOI: 10.1016/j.metabol.2020.154254] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
404 de las Heras Flórez S, Rodríguez Afonso J, Carretero Pérez M, Sosa García RM. Usefulness of the laboratory parameters in the prognosis of patients hospitalized with COVID-19. Rev Med Lab 2020. [DOI: 10.20960/revmedlab.00040] [Reference Citation Analysis]
405 [DOI: 10.1101/2020.04.20.20072223] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Reference Citation Analysis]
406 [DOI: 10.1101/2020.05.07.20094987] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Reference Citation Analysis]